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Summary 
In the early embryos of Drosophila, the nuclei proliferate by invariantly 13 
synchronous nuclear divisions. After nuclear divisions, the cell cycle stops, the 
zygotic gene is activated, maternal transcripts are degraded and cellularization starts. 
The transition is commonly referred to as mid-blastula transition (MBT). Previously, 
evidences have been showed that the following factors were involved in controlling 
MBT: (1) the extension of interphases and the cell cycle regulators such as grapes. (2) 
the degradation of maternal RNAs, such as string mRNA, and (3) the expression of 
zygotic mitotic inhibitors, such as frühstart. However, the molecular mechanism for 
controlling number of nuclear divisions remains unclear. 
In order to investigate the role of the zygotic gene expression in regulating the 
onset of MBT, I used two approaches: (1) the dissection of genomic regulatory 
elements of frühstart. (2) the phenotypic analysis of a novel RNA polymerase II allele, 
RPII215X
161
. Via a reporter assay, we identified two motifs at the frs promoter region 
which prevent the premature expression of frühstart. By EMSA, we identified 
anonther motif which show protein binding and is required for the strong frs 
expression. By analysis of a novel RNA polymerase II allele, RPII215
X161
, we 
identified a single nucleotide exchange in the 3‟-untranslated region of RPII215X161, 
which leaded to higher level of protein and transcrips in early embryo. Half of the 
mutant embryos (independent of the zygotic genotype) undergo only 12 nuclear 
divisions and start cellulariztion precociously. In addition, zygotic genes slam and 
fühstart are expressed earlier and maternal transcripts of CDC 25 homologs, string 
and twine are degraded earlier than normal in all embryos. Our data demonstrated 
zygotic gene activation paly an essential role regulating the timing and coordination 
of MBT.
_____________________________________________________________Zusammenfassun 
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Zusammenfassun 
Im frühen Embryo vermehren sich die Kerne zunächst durch 13 synchrone 
Kernteilungen. Nach den Kernteilungen stoppt der Zellzyklus, die zygotische 
Transkription wird aktiviert, maternale RNAs werden abgebaut und die Zellularisation 
beginnt. Dieser Ü bergang wird allgemein als mid-blastula transition (MBT) 
bezeichnet. Es konnte gezeigt werden, dass (1) die Verlängerung der Interphasen und 
Regulatoren des Zellzyklus wie z.B. grapes, (2) der Abbau maternaler RNAs wie z.B. 
string mRNA und (3) die Expression zygotischer Mitoseinhibitoren wie z.B. frühstart 
an der zeitlichen Koordination des Ü bergangs beteiligt sind. Trotzdem ist der 
molekulare Mechanismus zur Kontrolle der Kernteilungszahl immer noch unbekannt. 
Um die Rolle der zygotischen Genexpression bei der Regulation des MBT-Starts zu 
erforschen, wurden zwei Ansätze gewählt: (1) Die Analyse genomischer 
Regulationselemente von frühstart. (2) Die phänotypische Analyse eines neuen RNA 
Polymerase II Alleles, RPII215X
161
. Mittels Reporterassay wurden zwei Motive in der 
Promoterregion von frühstart identifiziert die eine verfrühte Expression von frühstart 
verhindern. Mittels EMSA wurde ein weiteres Motiv identifiziert, an das Proteine 
binden und das für eine starke frühstart Expression notwendig ist. Die Analyse des 
neuen RNA Polymerase II Allels RPII215X
161 
ergab einen Einzelbasenaustausch 
innerhalb der 3„-untranslatierten Region der RNA Polymerase II, der zu erhöhten 
Protein- und Transkriptmengen im Embryo führt. Die Hälfte der mutierten 
Embryonen (unabhängig vom zygotischen Genotyp) durchlaufen nur 12 
Kernteilungszyklen und beginnen dann verfrüht mit der Zellularisation. Zusätzlich 
werden in allen Embryonen die zygotischen Gene slam und frühstart verfrüht 
exprimiert sowie die maternalen Transkripte der string und twine früher abgebaut als 
im Wildtyp. Die Daten zeigen, dass die Aktivierung zygotischer Gene eine essentielle 
Rolle bei der zeitlichen Regulation und Koordination der MBT spielt. 
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Abbreviations  
3‟UTR three prime untranslated region 
5‟UTR five prime untranslated region 
aa  amino acid (s)  
ATP adenosine triphosphate 
bcd bicoid gene 
bp  base pairs  
cDNA  complementary DNA  
cv crossveinless gene 
D. Drosophila 
DAPI  4‟,6‟-Diamidino-2-phenylindole  
ddH2O  double distilled water  
DNA  deoxyribonucleic acid  
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EMSA Electrophoretic Mobility Shift Assay  
frs frühstart gene 
g  gram (s)  
GFP  green fluorescent protein  
GLC germline clone 
grp grapes gene 
hr  hour (s)  
HEPES  N-(2-Hydroxyethyl)piperazine-N‟(2-ethanesulfonic acid)  
HSP70 heat shock protein 70 
Ig  immunoglobulin  
in situ in situ hybridization 
IPTG  isopropyl-β-D-thiogalactopyranoside  
kb  kilobases  
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l  liter (s)  
MBT mid-blastula transition 
MNK MAP kinase signal integrating kinase 1 
N/A not available, 
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Pol II RNA polymerase II 215 subunit protein 
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pn prune gene 
RPII215 RNA polymerase II 215 subunit gene 
SDS Sodium dodecyl sulfate 
Slam slow as molasses protein 
slam slow as molasses gene 
sn singed gene 
SNP Single Nucleotide Polymorphism 
stg  string gene 
twn twine gene 
v vermilion gene 
w white gene 
WT Wild type 
y yellow gene 
zld zelda gene 
ZGA zygotic gene activation 
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1. Introduction 
1.1. The Mid-blastula transition 
The cleavage stage is the first development process after fertilization in 
development of animals with big eggs. During the cleavage stage, the large fertilized 
egg is split into increasingly smaller cells by rapid and synchronized cell divisions. 
The cleavage cycles are specialized cell cycles, which contain only the S phase and M 
phase, but lacking the gap phase. The length of cleavage divisions is very short, for 
example, the average length of the first 8 cycles is 8 min in Drosophila. In most 
animals, these divisions are supported by maternal transcripts and proteins.  
The cleavage cycles gradually slow down, eventually stop, and lose synchronicity. 
This transition is described as “transition blastuleenne” first by Jacques Signoret and 
Jacques Lefresne (KORZH 2009; SIGNORET J. 1971) and Gerhart referred to it as the 
mid-blastula transition (MBT, Figure 1.) (GERHART 1980). 
The further investigation by J. Newport and M. Kirschner revealed that there are 
other events occurred at mid-blastula transition, includes the onset of zygotic 
expression, degradation of maternal transcripts and morphological changes (NEWPORT 
and KIRSCHNER 1982a; NEWPORT and KIRSCHNER 1982b). Mid-blastula transition has 
been characterized in various model animals (e.g. Xenopus, Danio, and Drosophila) 
(EDGAR et al. 1986; KANE and KIMMEL 1993). Because cleavage cycles is relative 
simple and the clear cut of proliferation and morphological change, mid-blastula 
transition can be regarded as a simple model of a switch between cell proliferation 
and morphogenesis in development. 
_________________________________________________________________________Introduction 
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Figure 1: Summary of the events during mid-blastula transition. (a) the rapid nuclear 
divisions slow down and pause. (b) the maternal transcripts aredegraded. (c)Zygotic genes are 
transcripted (d) cellularization starts 
 
The onset of MBT and the number of cleavage cycles is very precise and robust. 
The number of cleavage cycles is precisely regulated in the given species, for example, 
there are 13 cleavage cycles in Drosophila, 12 in Xenopus and 11 in Zebra fish (KANE 
and KIMMEL 1993; YASUDA and SCHUBIGER 1992). Even when the embryos develop 
at various harsh environments; the number of cleavage cycles remains constant and 
the all the events still occur at the time. For example, the embryogenesis of 
Drosophila take almost two times longer at 18°C than at 25°C, however, the number of 
cleavage cycles is still 13. Cleavage cycles also have high resistance against UV 
radiation (YASUDA et al. 1991). 
 
1.2. The Cell Cycle during early development of Drosophila 
In insects, the cleavage stage is slightly different compared to other organisms. The 
embryo undergoes thirteen rapid and synchronous mitosis without cytokinesis 
_________________________________________________________________________Introduction 
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therefore generate a syncytial blastoderm that contains six thousand nuclei within a 
bulk cytoplasm (Figure 2B). Some nuclei fall into the yolk and undergo endocycles 
while other nuclei migrate to the periphery (Figure 2D). Since cycle 8, the degradation 
of Cyclins could be observed at mitosis (EDGAR et al. 1994b). The cell cycles 
gradually slow down from cycle 8. At cycle 14, the cell cycle pauses and the 
membrane invaginates from the surface and encloses the nuclei and form individual 
cells by a specific process called cellularization. After cellularization, the embryo goes 
into gastrulation and cell cycle is no longer synchronous. The transition is similar to 
mid-blastula transition in other metazoan.  
 
Figure 2: The models of cell cycle during early Drosophila development. (A) The general 
cell cycles contain G1, S, G2 and M phases. (B) the cleavage cycles contain only S and M 
phases without cytokinesis. (C) After cycle 8, G2 phase presents and interphase is prolonged. 
(D) the yolk nuclei undergo endocycles, which contain rounds of DNA replication without 
an intervening mitosis 
 
One factor involved in controlling the timing of MBT is the nucleocytoplasmic 
ratio (N/C) (NEWPORT and KIRSCHNER 1982a; NEWPORT and KIRSCHNER 1982b). 
When observing the ligated embryos or the embryos with different ploidy (Figure 3), 
the cleavage cell cycle pauses when the ratio of DNA to cytoplasm reaches a specific 
threshold (EDGAR et al. 1986; ROTT and SHEVELEVA 1968). In haploid embryo, there 
is one extra cleavage division compared with diploids; in contrast there is one 
cleavage less in the tetraploid embryo.  
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15 
 
 
Figure 3: N/C ratio controls number of cleavage cycles in embryos. The wild type (2N) 
undergoes 12 cleavage cycles. The haploid embryo undergoes one extra cycles while the 
tetraploid undergoes one cycle less. 
 
In 1984, Newport and Kirschner proposed the titration model. In this model, 
chromosomes titrate certain unknown cytoplasmic factors repress the transition until 
its level reaches a critical value. The rate-limiting cytoplasmic factors apparently 
control DNA replication (NEWPORT and KIRSCHNER 1984; POURQUIE 1998). During 
the early cleavage cycles, N/C ratio is low and cell cycles proceed. Since there is no 
cell growth during cleavage stage, N/C ratio became higher and when it reaches a 
certain threshold, cell cycle stops. It is proposed that there may be a cytosolic factor 
which would be gradually depleted during DNA duplication, and eventually the 
amount of this factor is lower than a threshold, the cell cycle stop.  
By manipulating chromosomal aberration in Drosophila, Lu and colleagues found 
that the DNA content threshold is required for mitosis stop the cleavage cycle is about 
70% of the amount normally present at cycle 14. This threshold between the DNA 
present at cycle 13 and cycle 14 may ensure the robust decision-making to define the 
_________________________________________________________________________Introduction 
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onset of MBT and tolerate the fluctuations of cytoplasmic volume(LU et al. 2009). 
The injection of lamda plasmid DNA at level of 2.5ng/embryo is sufficient to 
severely slow down the cleavage cycle and activates the checkpoint kinase 1 pathway 
in early Xenopus embryo. This level is equivalent to the DNA content of MBT (CONN 
et al. 2004; PENG et al. 2007). This result suggests that the sensor for the N/C ratio 
must sense the amount of DNA directly, but not other chromosome structure or 
nuclear materials. However, this extact factor remains illusive. 
Another specific issue concerning the N/C ratio in Drosophila is how individual 
nucleus responds to N/C ratio. Although all the synctial nuclei are in the same 
cytoplasm, there may still be local difference for the composition of cytoplasm. It is 
possible that the embryo decides to stop the cell cycle as a whole, but it is not true 
since the patchy embryos containing patches of different nuclear density were 
observed (Figure 4). This observation also rejects the idea that individual nuclei 
responds to its surrounding and makes the decision individually. If it were this case, 
the embryo would show salt and pepper pattern. Therefore the most likely model is 
that there would be some local communication between neighboring nuclei to decide 
when to stop the cell cycle collectively (LU et al. 2010). 
 
Figure 4: the decision making of cell cycle stop is regional (adapted from Lu 2009). The 
patchy embryo is the only intermediate phenotype observed when the cell cycle control is 
altered.  
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The CDC25 protein phosphatases play an important role in controlling the cell 
cycle. The Cyclin-dependent kinase is inactive when being phosphorylated on 
Threonine 14 and Tyrosine 15 by the inhibitory kinases Wee1 and Myt1 (RUSSELL and 
NURSE 1987a; RUSSELL and NURSE 1987b). CDC25 protein phosphatasez 
dephosphorylate T14 and Y15 of Cdk and promotes cells ito motosis (Figure 5)  
(EDGAR et al. 1994a; EDGAR and O'FARRELL 1990; RUSSELL et al. 1989; RUSSELL and 
NURSE 1986; STRAUSFELD et al. 1991). 
In Drosophila, there are two CDC 25 homologs, string and twine. Both of them are 
present maternally in early embryo, and are degraded at cycle 14. 5% of twn- 
overexpressd (6 copies) embryos undergo an extra mitosis, while 10% of the 
heterozygous twn with homozygous stg have only 12 mitoses. Therefore, the dose and 
degradation of CDC25 homologous is required for proper stop of cell cycle at MBT. 
The degradation of stg and twn requires the zygotic activation (EDGAR and DATAR 
1996; EDGAR et al. 1994b). 
 
Figure 5: CDC 25 phosphatase activates the cyclin-CDK complex by removing the inhibitory 
phosphate. The cyclin-CDK is phosphorylated by CAK which activated it, however, 
cyclin-CDK is also phosphorylated by Wee1/Myt 1 which inhibits cell cycle. The removal of 
this in inhibitory phosphate by CDC25 is essential for cell cycle progression. 
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Another zygotic contribution to stop the cell cycle is the expression of zygotic 
inhibitors of cell cycle. The cell cycle inhibitors frühstarts and tribbles express at 
early cycle 14 and are sufficient to stop the cell cycle (GROSSHANS et al. 2003; 
GROSSHANS et al. 2005). 
During the cleavage stage, the DNA damage checkpoint pathway is not activated. 
The DNA damaging agents UV radiation or injection of DNA double-strand breaks 
(DSB) fails to activate the checkpoint pathway and prevent the cell cycle progression 
before MBT. But the experiment show that checkpoint kinase can be activated prior 
the MBT if the DSBs are co-injected with the sufficient amount of uncut plasmid 
DNA (roughly equivalent to the DNA content at 10th embryonic division). This result 
suggests that actually all the components of the DNA checkpoint pathway are 
supplemented maternally into the embryos but are inactivated by an unknown 
mechanism and only activated at MBT. Also, the result suggests the activation of 
DNA checkpoint pathway is controlled by the nuclear-cytoplasmic ratio and the 
activation of checkpoint pathway is slightly prior MBT. The lack of DNA checkpoint 
ensures the rapid and synchronous cycles to produce large amount of cells in very 
short period. 
However, the activation of DNA checkpoint pathway is not just the consequence of 
MBT, but also plays an important role in prolonging the interphase and stop the 
cleavage cycle. In Drosophila, the mutations in checkpoint kinase 1 homologue, 
grapes (grp) block the cellularization and repress the gradual increase of interphase in 
division 11-13.  
It is proposed that the function of grapes in increase in cell cycle time is via the 
phosphorylation on CDC25 phosphatase and leading it to degradation. CDC25 
phosphatase dephosphorylates and activates CDKs, therefore, promotes the cell cycle. 
The removal of CDC25 protein and transcripts is required for the proper stop of cell 
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cycle at MBT. Therefore, String and Twin, the CDC25 homologous, seems to be good 
candidate targets for chk 1. However, checkpoint kinase 2, mnk, suppresses the 
cellularizarion and zygotic activation defects in grp, but does not restore cell cycle 
timing or replication-checkpoint function. This leads to the hypothesis that the lack of 
grp induces the DNA damage, which activates a Chk2-dependent block to 
developmental progression.  
1.3. Degradation of Maternal Transcripts 
Prior to the MBT, the early developmental events are driven exclusively by the 
maternal transcripts and proteims. It is estimated that there are about 6500 to 7700 
distinct mRNAs loaded into the eggs (DE RENZIS et al. 2007; TADROS et al. 2007a; 
TADROS et al. 2007b). Many of these maternal transcripts are degraded at MBT. 
Among these transcripts, about 1600 distinct mRNAs (20%) would be in unfertilized 
eggs, indicated a MBT-independent degradation pathway. However, in fertilized and 
activated embryos, about 33% of maternal transcripts would be degraded 
dependenting on MBT (Figure 6). The level of the other maternal transcripts is not 
obviously changed, which means either they are immediately replaced by zygotic 
transcripts or they are very stable and not degraded at MBT (DE RENZIS et al. 2007; 
TADROS et al. 2007a; TADROS et al. 2007b).  
Therefore, the degradation of maternal transcripts is mediated by two distinct 
pathways. The first one is driven by the maternally loaded protein/transcripts, which 
function even without fertilization or egg activation; the second pathway is dependent 
on zygotic activation (BASHIRULLAH et al. 1999).  
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Figure 6: Degradation profiles of maternal transcripts during MZT (adapted from Tadros, 
2009). There are different types of maternal transcripts: stable mRNA, like rpA1; degraded 
mainly by maternal pathway, like nos, or mainly zygotically, like bcd; or by both maternal 
and zygotic pathways, like hsp83. 
 
Bashirullah also identified two loci, cortex and grauzone, which are required for the 
maternal degradation pathway. Another RNA binding protein, Smaug (SMG) is 
identified as a key factor mediating the maternal transcript destabilization and 
translation repression in early embryos (DAHANUKAR et al. 1999; TADROS et al. 
2007a). SMG can bind to a specific RNA motif, SMG recognition elements (AVIV et 
al. 2003; SMIBERT et al. 1996). SMG recruits the CCR4/POP2/NOT-deadenylase 
complex to the target mRNA, then mediates the deadenylation to remove the poly-A 
tail of mRNA and leads to degradation (SEMOTOK et al. 2008). Piwi-associated RNAs 
(piRNAs) also involved in CCR4-mediated deadenylation and translation repression 
(ROUGET et al. 2010).  
The small non-coding RNA plays an important role in the zygotic degradation 
pathway. In zebra fish, the zygotic-expressed miR430 is required and sufficient to 
promote the degradation of more than 750 maternal transcripts(GIRALDEZ et al. 2006). 
In Drosophila, the miR-309 family of miRNAs also target the maternal transcripts for 
degradation in a similar manner as the miR430 in zebrafish (BUSHATI et al. 2008).  
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1.4. Zygotic Gene Activation (ZGA) 
Although the major activation of zygotic gene expression is at cycle 14, some 
zygotic genes, like the sex-determination gene, can be detected as early as in cycle 8 
(ERICKSON and CLINE 1993).  
Zygotic activation is required for the final pause of the cell cycle, part of the 
maternal degradation, cellularization and gastrulation (EDGAR and DATAR 1996; 
EDGAR and SCHUBIGER 1986; NEWPORT and KIRSCHNER 1982b). When α-amanitin, 
inhibitor of RNA polymerase II, is injected into the early embryo, the cell cycle 
continues for one additional nuclear division.  
Combining the genetics with large chromosome deletion and genome-wide analysis, 
De Renzis and his colleagues have identified the relative maternal and zygotic 
contribution for the expression of each individual gene during MBT(DE RENZIS et al. 
2007). It is estimated that there are 1158 genes which expressed zygotically. Among 
them, 334 genes can be considered pure zygotic. It means they are not only expressed 
zygotically but also are absent or at very low level in unfertilized or 0 to 1 hr 
embryos(DE RENZIS et al. 2007). The remaining 824 zygotic genes replace the 
corresponding maternal transcripts. 
Further genome-wide analysis between the haploid and wild-type embryos revealed 
that there were two subsets of pure zygotic genes. One is N/C dependent, which only 
contains minority of genes (88 out of 290). The remaining are N/C independent. 
However, within these two groups, the function of genes is heterogeneous, and the 
function of genes in these two groups are overlapping(LU et al. 2009). 
Frühstart (frs) is one of the known zygotic gene responding to N/C ratio. It was 
reported to involve in the mesoderm invagination (mitotic domain 10) by delaying the 
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entry into mitosis (GROSSHANS and WIESCHAUS 2000). Further examination showed 
that frühstart was also involved in the pause of the cleavage cell cycle after 13 nuclear 
divisions, ensuring a proper cell number and timed onset of cellularisation 
(GROSSHANS et al. 2003). Frs encode a 90 amino-acids peptide which competes the 
hydrophobic patch of cyclin E with the subtracts of cyclin/CDK complex(GAWLINSKI 
et al. 2007). 
Frs has a narrow expression peak starting only at the early cycle 14, correlates the 
pause of the cleavage cycles and MBT. The expression of frs is delayed to the extra 
division in haploid embryos (Figure 7), while other zygotic gene, like nullo, is still 
expressed at cycle 14. The expression of frs responds to N/C ratio and may serve a 
curial link between the pause of cell cycle and nucleocytoplasmic ratio. In order to 
reveal the mechanism how the MBT is initiated and how the number of nuclear 
division cycles is determined by the N/C ratio, I propose to investigate the 
transcriptional regulation of frs. 
 
Figure 7: The expression of frs as a readout of N/C ratio. (A)the expression profile of 
frs. Blue: diploid, red: haploid. (B)in situ hybridization of frs in diploid and haploid 
embryos (adapted from Grosshans, 2003). 
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Many zygotic genes share a common motif at their upstream region. This motif is 
called TAGteam (CAGGTAG) (DE RENZIS et al. 2007; ERICKSON and CLINE 1998; 
TEN BOSCH et al. 2006). Through the yeast one -hybrid analysis, Liang and her 
colleagues identified the zinc-finger transcription factor, Zelda (LIANG et al. 2008). 
Zelda specifically binds to the TAGteam motifs and is required for the expression of 
early zygotic genes before cellularization. Although Zelda is one of the key activator, 
zld mRNA already presents maternally. Zelda may need to be activated by other 
factors at MBT, or there may be some other transcription factors involved to give a 
fine regulation. Since Zelda is required for the expression of N/C dependent and N/C 
independent zygotic genes, the later idea for the contribution of other factors seems 
reasonable.  
Although the earliest zygotic transcript can be detected at cleavage cycle 8, the 
majority of the zygotic genes starts at early cycle 14. It is quite reasonable to assume 
that there is the global inactivation mediated by an epigenetic mechanism. In Xenopus, 
it is showed that the DNA methylation is required for the overall transcriptional 
silencing before MBT. When the DNA methyltransferase 1 (xDnmt1) is depleted, the 
zygotic transcription activates approximately two cell cycles earlier then normal in 
Xenopus (STANCHEVA and MEEHAN 2000). However, the RNA interference against 
Dnmt2, the only DNA methyltransferase in Drosophila genome, causes no obvious 
effect in early Drosophila embryogenesis (KUNERT et al. 2003). It remains uncertain 
whether there is a transcriptional repressor or general silencing mechanism preventing 
the early zygotic activation before MBT in Drosophila. However, SMG is also 
required for the zygotic gene activation, which can be explained by the degradation of 
maternal transcript of transcriptional repressor by SMG (Figure 8) (BENOIT et al. 2009; 
TADROS and LIPSHITZ 2009). 
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Figure 8: SMG may affect the ZGA by remove transcription repressor (adapted from Tadros, 
2009). The maternal expressed transcription repressor like TxnR inhibits the transcription 
before MBT; when SMG is gradually translated and promotes the degradation of the 
transcript of transcription repressor therefore reduces the repressor protein and the zygotic 
gene can be transcripted 
 
1.5. The coordination of events at MBT 
Although the features of MBT: the cell cycle pause, the maternal-zygotic transition 
and cellulatization, occur roughly simultaneously. Experiments show that there may 
not be one single mechanism controlling all events at MBT. Instead, different 
transitions control different events (YASUDA and SCHUBIGER 1992). Even the single 
event may be controlled by combination of distinct pathways. For example, the 
degradation of maternal transcripts is mediated by both maternal and zygotic 
degradation pathways. Another example is the zygotic genome activation. Two 
distinct categories of zygotic genes, N/C dependent and N/C independent, are 
observed. Instead of find a single mechanism controlling the whole MBT, the current 
challenge is understand how different events coordinate each other at MBT to 
continue the developmental process smoothly and thoroughly. 
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Aim of the studies 
To further investigating the mechanism how the timing of MBT is controlled, I 
used two approaches. First, I investigated the regulatory elements controlling frühstart 
(frs), whose expression responds to the N/C ratio. Secondly, I investigated the mutant 
X161, which showed premature pause of cell cycle, and caused the embryos 
underwent only 12 nuclear divisions. 
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2. Materials and Methods 
2.1 Materials 
2.1.1 Regents 
All standard chemicals were purchased from Sigma-Aldrich (Steinheim, Germany), 
AppliChem GmbH (Darmstadt, Germany), Serva (Heidelberg, Germany), Merck 
(Darmstadt, Germany) or Gibco BRL (Eggenstein, Germany) unless otherwise 
mentioned 
2.1.2 Radioactivity  
- Adenosine 5'-[γ-32P]-triphosphate (6000Ci/mmol, 220TBq/mmol), Hartmann 
Analytic GmbH 
- Deoxycytidine 5‟-[α-32P]-triphosphate (6000Ci/mmol, 220TBq/mmol), Hartmann 
Analytic GmbH 
2.1.3 Antibiotics 
-Ampicillin, stock (1000X): 100mg/ml, used in a final concentration: 50-200μg/ml. 
- Chloramphenicol: stock (1000x) 34 mg/ml, used in a final concentration of 34 μg/ml 
- Geneticin (G418): stock (1000X) 75 mg/ml, used in a final concentration of 75 
μg/ml 
2.1.4 Enzymes 
Restrict enzymes: all enzymes were purchased from Fermentas, New England 
Biolabs (Ipswich, USA) or Roche Diagnostics GmbH (Penzberg, Germany) and used 
according to the instructions delivered by the producers unless otherwise mentioned.  
The other enzymes used in this study is: Pfu DNA polymerase (prepared in the lab), 
Protease K (Roche), RNase A (Qiagen), SP6 RNA polymerase (Promega), Taq 
polymerase (prepared in the lab), T4 DNA ligase (Fermentas), T3 RNA polymerase 
(Roche), T7 RNA polymerase (prepared in the lab) 
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2.1.5 RNA probe for in situ hybridization 
All the RNA probes were labeled with digoxigenin-UTP (DIG-UTP), the RNA probe 
used in this study as followed: Dig αEGFP, Dig α slam, Dig α twin, Dig α string, Dig 
α bottleneck, Dig α nullo, Dig α hairy, Dig α frühstart. 
 
2.1.6 Primary antibodies 
Protein Against Animal 
Concentration 
Origin 
staining western 
-CID rabbit 1:1000  Stefan Heidmann, Bayreuth 
-Dig(Alkaline 
phophatase) 
sheep 1:2000  Roche 
-EGFP rabbit 1:1000  Torrey-Pines Biolabs 
-Frühstart rabbit 1:1000  Princeton 
-Frühstart guinea pig 1:1000  Charles River 
-β-galactosidase mouse 1:1000  Boehringer 
-p-Histone H3(S10) mouse 1:500  Millipore 
-kugelkern rabbit 1:1000  (BRANDT et al. 2006) 
-kugelkern guinea pig 1:1000  Charles River 
-Lamin Dmo mouse 1:1000  By H. Saumweber 
-Lamin Dmo guinea pig 1:1000  By G. Krohne 
-Pol II active form, H5 mouse 1:100 1:500 Millipore 
-Pol II, Ana 3 mouse  1:1000 Millipore 
-Pol II, CTD4H8 mouse  1:250 Millipore 
-Pol II, 8WG16 mouse  1:1000 Millipore 
-Slam rabbit 1:5000  Charles River 
-Slam guinea pig 1:5000  Charles River 
-α-Tublin mouse  1:5×106 Sigma 
-γ-Tublin mouse 1:1000  Sigma 
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2.1.7 Secondary Antibodies 
All the secondary antibodies used in this study were obtained from Invitrogen. 
 
2.1.8 Other reagents used in immunostainings  
- DAPI (4‟,6‟-Diamino-2-phenylindole): DNA staining, in a final concentration of 0.4 
μg/ml (Sigma-Aldrich)  
-oligreen (Molecular Probes, desicate at -20ºC): dilute 1:500 (stock, store at 4°C), 
stain at further 1:100 (strong) with 50 µg/ml RNaseA for at least 30 min. 
- Phalloidin-Alex 488: used for actin staining, in a final concentration of 6 nM (Molecular 
Probes)  
- Mounting medium: Aquapolymount (Polysciences, Eppelheim) 
 
2.1.9 Buffer  
- Genomic DNA extraction buffer: 
 
 
 
- DEPC water: 
 
 
- PBS:  
 
 
 
 
- PBST: 
 
 
- Fixation solution: 
 
 
 
30 mM  
100 mM 
19 mM  
 
2ml 
1 l 
 
130 mM 
7 mM 
3 mM 
 
 
 
 
 
5ml  
0,5 ml 
5ml 
 
Tris/HCl (pH 8) 
NaCl 
EDTA 
 
diethyl pyrocarbonate 
water 
 
NaCl 
Na2HPO4 
NaH2PO4 
adjust to pH 7.4 
 
0,2 % Tween 20 
PBS 
 
PBS 
Formaldehyde (37%) 
Heptane 
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-TAE: 
 
 
- TE: 
 
 
- 6xLadderbuffer: 
 
 
 
 
 
For in situ Hybridisation 
- NTP+Dig labeling mix (10x): 
 
 
 
 
 
- Transcription buffer (10x): 
 
 
 
 
 
- NBT/BCIP: 
 
 
- Hybridisation solution: 
 
 
 
 
- AP buffer: 
 
 
 
 
40mM 
1mM 
 
10mM 
1 mM 
 
10 mM 
0,03 % 
0,03 % 
60% 
60 mM 
 
 
10 mM  
10 mM 
10 mM 
6,5 mM 
3,5 mM 
 
400mM 
60mM 
100 mM 
20 mM 
100 mM 
 
75 mg/ml 
50 mg/ml 
 
50 % 
5x 
50 μg/ml 
100 μg/ml 
 
100mM 
50 mM 
100 mM 
0,2 % 
 
Tris-Ac 
EDTA 
 
Tris/HCl (pH8,0) 
EDTA 
 
Tris/HCl (pH 7,6) 
Bromophenol blue 
Xylenocyanol FF 
Glycerine 
EDTA 
 
 
ATP 
GTP 
CTP 
UTP 
Dig-11-UTP (Roche) 
 
Tris/HCl, pH 8,0 
MgCl2 
DTT 
Spermidine 
NaCl 
 
Nitrobluetetrazolium 
BCIP (X-phosphate, Sigma) 
 
formamide 
SSC 
heparin 
tRNA 
 
NaCl 
MgCl2 
Tris pH 9,5 
Tween 20 
 
_______________________________________________________________Materials and Methods 
30 
 
Fur medi plasmid DNA purification 
- Resuspension Buffer S1 
 
 
 
- Lysis Buffer S2: 
 
 
- Neutralization Buffer S3: 
 
 
- Equilibration Buffer N2: 
 
 
 
 
 
 
- Wash Buffer N3: 
 
 
 
 
- Elution Buffer N5: 
 
 
 
 
For min prep of plasmid-DNA 
- Solution I: 
 
 
- Solution II: 
 
 
- Solution III:  
 
 
50 mM 
10 mM 
100 μg/ml 
 
 
200 mM 
1 % 
 
2.8 M 
 
 
100 mM 
15 % 
900 mM 
0.15 % 
 
 
 
100mM 
15 % 
1.15 M 
 
 
100 mM 
15 % 
1 M 
 
 
 
50 mM 
10 mM 
 
1 % 
0.2 M 
 
3 M 
 
 
Tris/HCl 
EDTA 
RNase A 
adjusted to pH 8,0 
 
NaOH 
SDS 
 
potassium acetate  
adjutsted to pH 5,1 
 
Tris 
ethanol 
KCl 
Triton X-100 
adjusted to pH 6,3 with H2PO4 
 
 
Tris 
ethanol 
KCl 
adjusted to pH 6.3 with H2PO4 
 
Tris 
ethanol 
KCl 
adjusted to pH 8.5 with H2PO4 
 
 
Tris/HCl, pH 8 
EDTA 
 
SDS 
NaOH 
 
potassium acetate 
adjusted to pH 5.4 
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For isolation and fractionation of 
nuclei 
-Buffer A 
 
 
 
 
 
 
-Buffer B 
 
 
 
 
 
 
-Buffer C 
 
 
 
 
-High salt buffer 
 
 
 
For EMSA 
-5X Tris-glycine buffer: 
 
 
-2X binding buffer: 
 
 
 
 
 
-6X loading buffer: 
 
250mM 
 
 
350mM 
15mM 
10mM 
5mM 
500mM 
1mM 
 
800mM 
15mM 
10mM 
5mM 
500mM 
1mM 
 
15mM 
10mM 
3mM 
1mM 
 
15mM 
1M 
1mM 
 
 
12.5mM 
2M 
 
20mM 
20% 
0.2mM 
1mM 
0.5mM 
 
0.25% 
 
Tris 
 
 
sucrose 
Hepes/KOH pH7.5 
KCl 
MgCl2 
EGTA 
DTT 
 
sucrose 
Hepes/KOH pH7.5 
KCl 
MgCl2 
EGTA 
DTT 
 
Hepes/KOH pH7.5 
KCl 
MgCl2 
DTT 
 
Hepes/KOH pH7.5 
NaCl 
DTT 
 
 
EDTA 
glycine 
 
HEPES pH7.9 
glycerol 
EDTA 
tetrasodium pyrophosphate 
PMSF 
 
bromophenol blue 
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For western blot  
-Wet transfer buffer  
 
0.25% 
40% 
 
 
25mM 
175mM 
20% 
  
xylene cyanol 
sucrose 
 
 
Tris 
Glycine 
Methanol 
2.1.10 Media for bacterial culture 
- LB: 10 g bactotryptone, 5 g yeast extract, 10 g NaCl in 1l water, autoclaved. 
-LB plate: 10 g bactotryptone, 5 g yeast extract, 10 g NaCl, 15g agar in 1l water, 
autoclaved, then add required antibiotic at 55℃ 
 
 
2.1.11 Fly food 
10 l water together with 128 g thread agar was cooked for 2 h, till the agar is 
completely dissolved400 g fresh baker yeast, 160 g soja bean meal and 1,28 kg maize 
meal was suspended in 4 l water ,  mixed and was added to the agar and cooked 
another 2 h. 1,28 kg malt extract and 350 g sugar beet molasses was suspended  in 2 
l water and was added to the mixture. The food was cooked for 30 min and afterwards 
it will be cool down below 60°C. 24 g Nipagin (solved in ethanol) and 150 ml 
propionic acid was added, mixed and the fly food was filled up in vials. The vials 
were closed with plags and stored at 18°C. 
2.1.12 Apple juice plates 
70 g agar was dissolved in 3 l of water. In 1 l apple juice was dissolved 100 g of 
sugar in a 60 °C water bath. 40 ml Nipagin-solution (15 % Nipagin in ethanol) was 
added to the apple juice. The sweetened apple juice was added to the agar, mixed and 
cool down to 60°C. The apple juice agar was poured in Petri dishes and stored at 4°C. 
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2.1.13 Oligonucleotides 
Molecular Cloning 
Nr. Sequence 
SV1 ggc tcg agt aca tgg tgg tgg gga gat g 
SV5 gga tcg ata ata act gct agg ctg gc 
SV6 ggc tcg agc gaa ttc ctt tct aat tta ttg c 
SV7 ggc tcg agg cga gaa ttt tct gcg gaa at 
HS1 gtc gac ctg cgg aaa ttt taa tta tga gc 
HS2 gtc gac agt aat ggg ttt tag tct acc gc 
HS3 gtc gac agt gga tat aaa gaa ggc cgt g 
HS4 gtc gac aat atc tgc gcg gaa aat aca g 
HS5 gtc gac agt gac aga tgt gga aaa cgg ata ag 
HS6 gtc gac cta atc cct ttt taa tgc gtt cag 
HS7 gtc gac agt gac aga tgt gga aaa cgg 
HS8 gtc gac taa tgg gtt tta gtc tac cgc 
HS9 gtc gac gca cca taa aag tga cag atg tg 
HS10 gtc gac ctc ata att aaa att tcc gca g 
HS11 gaa ttc atg gtg agc aag ggc 
HS12 gaa ttc cta ctt gta cag ctc gtc c 
HS13 cgc ctc gag ggc agt gat tcc gat tta gca 
HS14 cgc ctc gag aga gac acc cgc aaa gag 
HS15 cgc ctc gag agt ggg ttc ttt cac ctg 
HS16 cgc gaa ttc atg gtg agc aag ggc 
HS17 cgc gaa ttc ctt gta cag ctc gtc c 
HS18 cta taa gtc gac agt gga tat aaa gaa ggc cgt g 
HS19 tcc act gtc gac aat atc tgc gcg gaa aat aca g 
HS20 tat gac gtc gac gca cca taa aag tga cag atg tg 
HS21 tgg tgc gtc gac ctc ata att aaa att tcc gca g 
HS22 gga aat ttt aat tat gag gtc gac gca cca taa aag tg 
HS23 gta gac taa aac cca tta gga gtc gac gtc gta att ctg aac gca 
HS24 tgc gtt cag aat tac gac gtc gac tcc taa tgg gtt tta gtc tac 
HS25 ctc gcg taa ttc tga acg gga gtc gac gtc att ag cga gaa ttt tct gcg  
HS26 c gca gaa aat tct cgc t aat gac gtc gac tcc cgt tca gaa tta cgc gag 
HS27 agg gat tag cga gaa tt gga gtc gac gtc ttt aat tat gag cag gta g 
HS28 c tac ctg ctc ata att aaa gac gtc gac tcc aa ttc tcg cta atc cct 
HS29 cag gta gca cca taa aag gtc gac aca tg gga aaa cgg ata agc tg 
HS30 ca gct tat ccg ttt tcc ca tgt gtc gac ctt tta tgg tgc tac ctg 
HS31 ctg tat ttt ccg cgc a gga gtc gac gtc agt cct gaa att gca cac 
HS32 gtg tgc aat ttc agg act gac gtc gac tcc t gcg cgg aaa ata cag 
HS33 g atg tgg aaa acg gat a gga gtc gac gtc att gca gat att tat ggc ag 
HS34 ct gcc ata aat atc tgc aat gac gtc gac tcc t atc cgt ttt cca cat c 
HS35 ctg cgg aaa ttt taa tta tga g gtc gac gca cca taa aag tga cag atg  
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HS36 cat ctg tca ctt tta tgg tgc gtc gac ctc ata att aaa att tcc gca g 
HS37 gcg aagctt tggag aacgt tgtta gcggtg 
HS40 cgc atc gat tgg aga acg ttg tta gcg gtg 
HS41 cgc ctc gag tgt gga aaa cgg ata agc 
HS42 cgc ctc gag gat tgg att att gaa agc 
HS43 cgc ctc gag ctt taa gga att att atc 
HS44 cgcatcgatggagaacgttgttagcggtg 
HS45 cgcggtaccccaacccgctcatctcgc 
HS46 ccggtcgaccatgcagccgccgcactg 
HS47 cgcctcgaggatgttgagacatatcctg 
HS48 ccgatcgat cga gcg gcg ggc ata tat ac 
HS49 ccg ggtacccatgcagccgccgcactg 
HS50 gca gga att cga tat caa gc 
HS51 ccg atc gat tgt gca att tca gga ctg c 
HS129 cgc ctc gag gac ttt atg gcg gta gac 
HS130 cgc ctc gag ccc att act acc tgc tcg 
HS351 cgctctagaccactgcatccgcgctggtg 
HS352 gccgcggccgcgagtggccgcactggctctc 
HS357 ctcccccagcacgtcccgaactccggggcggtcaag 
HS358 cttgaccgccccggagttcgggacgtgctgggggag 
HS363 agcctgagaaacggctacca 
HS364 agctgggagtgggtaatttacg 
HS365 ctagctcagtcggtagagcatga 
HS366 ccaacgtggggctcgaac 
 
Oligos for the EMSA 
Nr. Sequence 
HS52 agc ttg cat ctt cag tta tcg gtt atg cgg cgt tta ag 
HS53 tcg act taa acg ccg cat aac cga taa ctg aag atg ca 
HS54 cgg agt act gtc ctc cgc gga gta ctg tcc tcc gcg gag tac tgt cct cc 
HS55 gga gga cag tac tcc gcg gag gac agt act ccg cgg agg aca gta ctc cg 
HS56 att ctg aac gca tta aaa agg gat tag cga gaa tt 
HS57 aat tct cgc taa tcc ctt ttt aat gcg ttc aga at 
HS58 ttt ccg cgc aga tat tta tgg cag tcc tga aa 
HS59 ttt cag gac tgc cat aaa tat ctg cgc gga aa 
HS52 agc ttg cat ctt cag tta tcg gtt atg cgg cgt tta ag 
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HS53 tcg act taa acg ccg cat aac cga taa ctg aag atg ca 
HS54 cgg agt act gtc ctc cgc gga gta ctg tcc tcc gcg gag tac tgt cct cc 
HS55 gga gga cag tac tcc gcg gag gac agt act ccg cgg agg aca gta ctc cg 
HS56 att ctg aac gca tta aaa agg gat tag cga gaa tt 
HS57 aat tct cgc taa tcc ctt ttt aat gcg ttc aga at 
HS58 ttt ccg cgc aga tat tta tgg cag tcc tga aa 
HS59 ttt cag gac tgc cat aaa tat ctg cgc gga aa 
HS63 cag tcc tga aat tgc ac 
HS64 gtg caa ttt cag gac tg 
HS65 gga aaa cgg ata agc tgt att ttc cgc gca 
HS66 tgc gcg gaa aat aca gct tat ccg ttt tcc 
HS67 acc ata aaa gtg aca gat gtg gaa aac gga 
HS68 tcc gtt ttc cac atc tgt cac ttt tat ggt 
HS69 ttt aat tat gag cag gta gca cca taa aag 
HS70 ctt tta tgg tgc tac ctg ctc ata att aaa 
HS71 gcg aga att ttc tgc gga aat ttt aat tat g 
HS72 cat aat taa aat ttc cgc aga aaa ttc tcg c 
HS73 Cattactacctgctcgcgtaattctgaacg 
HS74 Cgttcagaattacgcgagcaggtagtaatg 
HS75 gac taa aac cca tta cta cct gct cgc gta 
HS76 tac gcg agc agg tag taa tgg gtt tta gtc 
HS77 agg cgg act tta tgg cgg tag act aaa acc 
HS78 ggt ttt agt cta ccg cca taa agt ccg cct 
HS79 aat tta ttg cga ttt gta aaa ggc gga ctt 
HS80 aag tcc gcc ttt tac aaa tcg caa taa att 
HS81 ctc gag cga att cct ttc taa ttt att gcg 
HS82 cgc aat aaa tta gaa agg aat tcg ctc gag 
HS83 tta tgg tgc tac ctg ctc 
HS84 att atg agc agg tag cac cat a 
HS85 tat ggt gct acc tgc tca taa t 
HS86 aat tta ttg c 
HS87 gca ata aat t 
HS88 gat ttg taa a 
HS89 ttt aca aat c 
HS90 agg cgg act t 
HS91 aag tcc gcc t 
HS92 tat ggc ggt a 
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HS93 tac cgc cat a 
HS94 gac taa aac c 
HS95 ggt ttt agt c 
HS96 Atttgtaaaaggcggactttatggcggtag 
HS97 Ctaccgccataaagtccgccttttacaaat 
HS98 Ttgcgatttgtaaaaggcggactttatggcggtagactaa 
HS99 Ttagtctaccgccataaagtccgccttttacaaatcgcaa 
HS100 Cgaattcctttctaatttattgcgatttgtaaa 
HS101 Tttacaaatcgcaataaattagaaaggaattcg 
HS102 Tttctaatttattgcgatttgtaaaaggcg 
HS103 Cgccttttacaaatcgcaataaattagaaa 
HS104 Attgcgatttgtaaaaggcggactttatgg 
HS105 Ccataaagtccgccttttacaaatcgcaat 
HS106 Gatttgtaaaaggcggactttatggcggta 
HS107 Taccgccataaagtccgccttttacaaatc 
HS108 Gtaaaaggcggactttatggcggtagacta 
HS109 Tagtctaccgccataaagtccgccttttac 
HS110 Gactttatggcggtagactaaaacccatta 
HS111 Taatgggttttagtctaccgccataaagtc 
HS112 Tatggcggtagactaaaacccattactacc 
HS113 Ggtagtaatgggttttagtctaccgccata 
HS114 Cggtagactaaaacccattactacctgctc 
HS115 Gagcaggtagtaatgggttttagtctaccg 
HS116 aatttattgcgatttgtaaaaggcggactttatggcggtagactaaaacc 
HS117 gaaattgttacgaattcc ga gtc gac gtc att a gatttgtaaaaggcggac 
HS118 gtccgccttttacaaatctaatgacgtcgactcggaattcgtaacaatttc 
HS119 cctttctaatttattgc ga gtc gac gtc att a gactttatggcggtagac 
HS120 gtctaccgccataaagtctaatgacgtcgactcgcaataaattagaaagg 
HS121 ctaatttattgcgatttgtaaa ga gtc gac gtc att a cggtagactaaaaccc 
HS122 gggttttagtctaccgtaatgacgtcgactctttacaaatcgcaataaattag 
HS123 gtaaaaggcggactttatgg ga gtc gac gtc att a cattactacctgctcgcg 
HS124  cgcgagcaggtagtaatgtaatgacgtcgactcccataaagtccgccttttac 
HS127-bio bio-ccc tgg aca gca aga agt att c 
SV5-biotin bio-cct cga gcg aat tcc ttt cta att tat tgc 
 
SNP mapping 
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Nr. Sequence 
HS131 tcc tcg cat tca ttt ctc gca ca 
HS132 acg gct ctc gct ttc tcc ttc ca 
HS133 ctt gtg tgc gtg cgt gtg tgt gt 
HS134 cct gct gcg gtt tca gtt gtc att tt 
HS135 tcg gtg tgc gtt ttg ttc tgg ttt t 
HS136 tgg aca cag cag gag cag agt agg tg 
HS137 cac agt ccg cgt caa gag caa ca 
HS138 agc cac atc ttc atc gtc ttc agc atc 
HS139 ttt ttg cca ttt ctg ctg ta 
HS140 gaa cat ttg tag cgt gca gat 
HS155 Gacaaaggcttcggcgatct 
HS156 tga aga ttc ttg gcg agc cg 
HS157 ttt tct tga ggg gcc tgg ga 
HS158 ggg aca ctg aag cgc taa gg 
HS159 cca ttc agc aag ccc ctg tt 
HS160 tgg gta tcg ggt agt cga gc 
HS161 cct cgt gtg gca agc gaa ta 
HS162 tct tgg cac gtt gtt gtc gt 
HS164 acg agt gtt ggc ctg tcg gg 
HS165 ggc cca gga gca agg caa ga 
HS166 ggc aca tgc cac acg cac aa 
HS167 gcc act gcc ttt tgc acc cc 
HS176 tcttggggtgatcacgcagc 
HS177 cat ggg tcc gca gaa cac g 
HS178 tcc tcg cat tca ttt ctc gc 
HS179 ggc tct cgc ttt ctc ctt c 
HS180 cat cca tcc aac cat cca tcc 
HS181 cga atg cca aga gcc aaa cac 
HS182 tgc ttc ctt gca ccc tta att tg 
HS183 cga ttt tcc gtc ccg tct gat 
HS184 cag cca gga tta cat ggg tgt c 
HS185 gtt ttt cgg cat ttc ggg ttt c 
HS186 gtc gac cgc cca aat gtc gc 
HS187 gcc ctc ccc cac ctt tcc ac 
HS188 agt ggt ggg gcg gaa atg gg 
HS189 cgg aaa cgg aag cgg aag cg 
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HS190 cga aca aat ggg cgg ggt gc 
HS191 ggg acg gca gaa acg ggg aa 
HS192 ctc tgg gct ccc cta tcc cc 
HS193 ctg cag aag gac gac ccc ac 
HS194 cac gat caa gcc cgc gtt tc 
HS195 agc atc ccc aac gaa cga cc 
HS196 cgg gga aga cca cgc atc tc 
HS197 cgg ctc tcg cca tct ctg tc 
HS198 agt caa gag cgg tga gtg cg 
HS199 tgg cag gag gtg cgg ttt tt 
HS200 aaa aac gcc gac tgc aca gc 
HS201 gat gga gaa ggg ttg ggc cg 
HS202 gtc gca ggc ccc ttt tcg ta 
HS203 agc ggg atg gca tca agg tg 
HS204 gtt tgc ggg tgc ggc ttt gg 
HS205 att ggc ctt ggg tca gcc gc 
HS206 cag cgc tcc tgg gaa cca gc 
HS207 act ccg cag gct ttt ccg cc 
HS215 gcc agc aaa ctg acc aca ga 
HS216 aat gca act gca gcg aaa gc 
HS217 ggt gga ggg agg aac gta ca 
HS218 aca ggc gtt gtt gct gtc at 
HS219 cca aaa gaa acg cac gcg aa 
HS230 aat tcg gag agc gga agt gc 
HS231 ata ttt cgc cct gca tgc gt 
HS232 tcg cgg gaa cgt ttc ttc tc 
HS233 tgc agc agc ggt act gaa tc 
HS234 agc gtt ttg ggt ctg gga ac 
HS235 gaa ggg cag taa ctc gct gg 
HS236 ggc ggc ttc ttc ttc gct ta 
HS237 cgg tgt atc atg tgg cag ca 
HS238 cgg aat gcc tca ctc act gg 
HS239 gtg gcc caa aaa gcg cca gc 
HS240 ctg tct gcc agc aac ccc cg 
HS241 gcg gga aac act gct ccg ct 
HS242 ctg gtc ctt ggc cgc cct tg 
HS243 cct cca tag ccc cca ccc cc 
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HS244 agt ttc agc ttc gcc ccg cc 
HS245 gtc cgt gtc ctt gcc cct gc 
HS246 gac tgc cgc aca gcc gga at 
HS247 atc gcc tgg cgt ggc caa aa 
HS248 cgt tgc gat gcg tta gcg gc 
HS249 gcc cca aag ctg ctc cgg tt 
HS250 ttc tgc tcg ctt ggg tgg cg 
HS251 ggg aag ggc acg cac aga cc 
HS252 ttg cca att gcc cac ccg ca 
HS253 ttc agc atg ccg ccg ttg at 
HS254 cgc ctc ccc tct ctc gct ca 
HS255 tca ccg gcg tat cgg agg ga 
HS256 tcg ata gga acc tgc gcg gc 
HS257 gcg atc ggt ggg tgc tgc ta 
HS258 tcc ctc cga tac gcc ggt ga 
HS259 cat ccg gca gct ggc cac aa 
HS260 aat gcg acg tga gcg gag gc 
HS261 ggc agc acg cga ttc cga gt 
HS262 ttg tgg cca gct gcc gga tg 
HS263 ctg ttc gtt ttc cct ttg gtg 
HS264 cgt cat cgt cat cct cgt cct 
HS265 cgt tcc cca tct acc ttc att tc 
HS266 act gtt cct ctc act tgg aca cct 
 
Oligos for sequencing 
Nr. Sequence 
HS279 gtcaaagttcagagctttc 
HS280 cagaggacgaatcctaac 
HS281 ctaaccttaccgcaataaag 
HS282 ggatttggacttttctaccc 
HS283 agaagaagaaccggagccgg 
HS284 agccgccaatgttaagctcg 
HS285 agactggtaggcgaatgtac 
HS286 caaggagttcaagctgccgc 
HS287 gatttcggcagcaacagctc 
HS288 aaagtccaaatccactcacc 
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HS290 gtgttgtgatgttggtacag 
HS291 gcaacatctagctgctctag 
HS292 acgtcttaaactgaatttgc 
HS293 aagagcctctgcacccagtg 
HS294 cacccaaaactcaggctgtc 
HS295 acatgcacaacgatccgaat 
HS296 tagaagagcgaattgatgaa 
HS297 cagtggaagtgcgagcagtg 
HS298 aaaggtgacctgctgctcgacgtc 
HS299 tcagcatcgtccaggcacag 
HS307 gcacttctgatgatggctgcc 
HS308 cgaccgaaaagtgtgactgc 
HS309 tgagaaggatgagcgaggcc 
HS310 gcggcaaggcatgatcctga 
HS311 aaatcggcctggaaggcttc 
HS312 acagccaagtaccgagaattcc 
HS313 caccagcaaatttgttggc 
HS314 cacaattaaagcatgccgac 
HS315 ggctatctgaagactttccc 
HS316 gacgatctatgtgagtataatc 
HS317 gcggcatttaagcactaaag 
HS320 gaacagagcggacaccccg 
HS321 atccatgtcctcgccgccc 
HS322 gcgtaagcgcctggcctacg 
HS323 tccacgaaaccgcgcgactc 
HS324 tgacaagactggtggttcggcc 
HS325 cgtccgtctcgagcagccac 
HS326 ggacgaagacgaggccgtc 
HS327 gggacgtgctgggggagc 
HS328 cttttcggtcggcgttgtcc 
HS329 tccagtaacgcgagcaggac 
HS330 agcttcgcaagaacgaggcc 
HS331 tgaacctgtcgtgtacatcgcc 
HS332 tcgtcttataaaggctatggagtcg 
HS333 gcgtttgagtggttggtcgg 
HS334 cggctgctttgaccttctgc 
HS335 tgcaagtccacgttacgcatc 
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HS336 tgctggccatagaagtatctgtgg 
HS337 gtcggcatgcgagccttc 
HS338 caggcacccacccatacac 
HS339 tatggccattgggctggtgc 
HS340 acatgcccaacatctccgatag 
HS341 tttttccgctgactgcacacag 
HS342 tttttgtttagccgatgcaagc 
HS343 cgtaacaccctcatactcgccg 
HS344 cggtgcccacacctatggatac 
HS345 gagcgaagactgaggaagggag 
HS346 gccaacgtcagacactatttgtagc 
HS347 tggcgagtacatcggtgacg 
HS348 cgcgagcaggacaacaaataac 
HS349 cgggcatatcgttgtccactag 
HS350 cgtccagtttgcggagacaatg 
 
Oligos for QPCR 
Nr. Sequence 
HS353 tatcccaggttattgcttgtgtggg 
HS354 gcagtatcgataagaccttcacgacc 
HS355 atcgagcacggcatcatcac 
HS356 cacgcgcagctcgttgta 
HS363 agcctgagaaacggctacca 
HS364 agctgggagtgggtaatttacg 
HS365 ctagctcagtcggtagagcatga 
HS366 ccaacgtggggctcgaac 
 
2.1.14 vectors 
The following vectors were used in this study: 
 pBS-KS(+)  (Stratagene, Waldbronn) 
pCasper 4         (Lab J. Grosshans) 
pATTB           (Lab Basler) 
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2.1.15 EST clones & BAC clones 
RE30267 
136G02 
161G23 
2.1.16. Column 
PD-10 desalting column    GE Healthcare Life Science, Uppsala, Sweden  
G-25 Sephadex column     GE Healthcare Life Science, Uppsala, Sweden 
 
2.1.17. Kits 
- MiniElute Gel extraction Kit   Quiagen, Hilden 
- Plasmid Midi Kit Nucleobond AX   Macherey-Nagel, Düren 
-Expand High Fidely PCR System Roche, Mannheim 
 
2.1.18. Bacterial cell lines 
- E.coli DH5-α F-, ø80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1, 
hsdR17(rK–, mK+), phoA, supE44, λ–, thi-1, gyrA96, relA1 
 
2.1.19. Fly stocks 
Most fly stocks were obtained from the Bloomington Drosophila Stock Center at 
Indiana University (http://flystocks.bio.indiana.edu/) unless otherwise mentioned 
-x9                          from Vogt EMS collection (VOGT et al. 2006) 
-X161                          from Vogt EMS collection (VOGT et al. 2006) 
-y, pn, cv, v, FRT
18E
                prepared by Grosshans 
-OvoD, FRT
18E 
 
-histone::GFP (3rd)                     prepared by Grosshans 
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-nullo/FM7; Cad::GFP, histone::RFP       prepared by Grosshans 
-nullo/FM7; sqh-meo::GFP               prepared by Grosshans 
-C(1)A, y1/Y/FM0 
- P{w[+mC]=ovoD1-18}P4.1, P{ry[+t7.2]=hsp70-flp}1, y[1] w[1118] sn(SHIBUTANI 
et al.) P{ry[+t7.2]=neoFRT}19A/C(1)DX, y[1] w[1] f[1] 
-w[1118] sn(SHIBUTANI et al.) P{neoFRT}19A 
-y1 arm1/FM7c 
-Df(1)BSC351, w[1118]/FM7h 
-Df(1)svr, N ras fw / Dp(1;Y)y 67g19.1 / C(1)DX, y f 
-Dp(1;f)R, y[+]/y dor[8] 
-Df(1)w258-45, y /Y/C(1)DX, y w f; Dp(1;3)w[vco] 
-Df(1)64c18, g sd /Dp(1;2;Y)w[+] /C(1)DX, y w f 
-Dp(1;2)w-ec, ec cm ct sn/C(1)DX, y w f 
-Df(1)dhd81, w/C(1)DX, y f; Dp(1;2)4FRDup /+ 
-Df(1)JC70/Dp(1;Y)dx[+]5, y[+]/C(1)M5 
-Df(1)ct-J4, In(1)dl-49, f/C(1)DX, y w f; Dp(1;3)sn[13a1]/+ 
-Df(1)GE202/Y & C(1)A, y/Y; Dp(1;2)sn[+]72d/Dp(?;2)bw[D] 
-Dp(1;Y)619, y[+] B[S]/w oc/C(1)DX, y fy nej v f/Dp(1;Y)FF1, y[+]/C(1)DX, y w f 
-Df(1)v-L15, y/C(1)DX, y w f; Dp(1;2)v[+]7 
-Dp(1;Y)BSC1, y[+]/w P{w[+mC]=lacW}l(1)G0060/C(1)RA, y 
-Df(1)v-N48, f[*]/Dp(1;Y)y[+]v[+]#3/C(1)DX, y f 
-C(1;Y)6, y w P{w[+*]=white-un4} BE1305 mew[023] / C(1)RM, y pn v;Dp(1;f)y[+] 
-C(1;Y)1, Df(1)g, y f B/C(1)A, y/Dp(1;f)LJ9, y[+] g[+] na[+] Ste[+] 
-Df(1)19, f/C(1)DX, y w f; Dp(1;4)r[+] 
-Dp(1;Y)W73, y B, f[+], B[S]/C(1)DX, y f/y baz[EH171] 
-Df(1)os[UE69]/C(1)DX, y f/Dp(1;Y)W39, y[+] 
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-Df(1)R20, y/C(1)DX, y w f/Dp(1;Y)y[+]mal[+] 
-Df(1)A113/C(1)DX, y w f; Dp(1;2)w[+]64b/+ 
-Df(1)dx81, w[*]/Dp(1;Y)dx[+]1/C(1)M5 
-Df(1)w258-45, y/Y/C(1)DX, y w f; Dp(1;3)w[vco], Pr 
Dp(1;Y)BSC47 
Dp(1;Y)BSC49 
Dp(1;Y)BSC50 
Dp(1;Y)BSC52 
Dp(1;Y)BSC54 
Dp(1;Y)BSC56 
Dp(1;3)DC233 
Dp(1;3)DC234 
Dp(1;3)DC235 
Dp(1;3)DC237 
Dp(1;3)DC238 
Dp(1;3)DC239 
Dp(1;3)DC240 
Dp(1;3)DC241 
Dp(1;3)DC243 
Dp(1;3)DC246 
RPII2151 
RPII215G0040 
Df(1)BSC287 
Df(1)BSC288 
Df(1)BSC541 
Df(1)BSC544 
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Df(1)BSC658 
Df(1)BSC722 
 
Generated in this work 
-w, X161, f, FRT18
E
 /FM7h 
-y, pn, cv, v, X161
m10+m12
, f, FRT
18E
/FM7h  
- y, pn, cv, v, X161
m12
, f, FRT
18E
/FM7h 
- y, pn, cv, v, RPII215
X161
, FRT
18E
/FM7h 
-X161; Tft/CyO 
-X161; △7/TM3 
-X161; Cad&his 
-X161; sqh-meoGFP 
-OVO; △19/TM3 
-OVO; Cad&his 
-OVO; sqh-meoGFP 
-OVO; histoneGFP 
 
2.1.20. Agarose gel electrophoresis 
- Gel electrophoresis chamber 
- Voltage source 
ZMBH fine mechanics workshop 
ThermoEC 135-90 
 
2.1.21. Microscopy 
- Injection-microscope 
- Leica MZ125 
- Zeiss Axioplan 2 Fluorescence microscope 
Carl Zeiss 
Leica 
Carl Zeiss 
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- Zeiss Axiovert 200 M Ultra-View Spinning 
Dsisc confocal microscope 
 
- Zeiss Stemi 2000 
 
Carl Zeiss 
 
 
Carl Zeiss 
 
2.1.22. Other materials 
- Coverslips 
-Electrophoresis cuvett 
- Fly vials 
- Glass pipetts (20 ml, 10 ml, 5 ml, 2 ml) 
- Pasteur pipetts  
- Petri dishes 
- Pipetboy 
- Pipettes (1000 μl, 200 μl, 20 μl, 2 μl) 
- Pipett tips (1000 μl, 200 μl, 2 μl)  
- Reaction tubes (50 ml, 30 ml, 15 ml, 1,5 ml) 
- Teaction tubes (2 ml, 1,5 ml) 
- Transfer pipetts 
- SperFrost Plus Slides  
- 10S VoltaLef Halocarbon Oil 
- 3S VoltaLef Halocarbon Oil 
Menzel 
peqLab 
Greiner 
Silber Brandt 
Brandt 
Greiner 
IBS Integra Biosciences 
Gilson 
Eppendorf, Hamburg 
Sarstedt, Nürnber 
Eppendorf 
Sarstedt, Nürnberg 
Menzel 
Lehmann & Voss & Co. 
Lehmann & Voss & Co. 
 
 
2.1.23. OtherEquipments 
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- Agarose gel rigistrator 
- Cetrifuge 5415D 
- Centrifuge 5417R 
- Electroporator 
- Glass needle maker 
- Heating block 
- IDA Gel Documentation System 
- Microinjection  
Multi Cycler PTC-200  
- NanoDrop-2000 spectrophotometer  
- Rotator Wheel 
- Speed Vac Concentratrator 5301  
- Thermomixer confort 
- Vortexer 
- Waterbath 
Paytest IDA 
Eppendorf, Hamburg 
Eppendorf, Hamburg 
Gene Pulser
TM
, BIO-RAD 
Narishige PN-30 
Techne Dri-Block 
Raytest 
FemtoJet, Eppendorf 
MJ Research 
peqLab, Erlangen 
neoLab Rotomix 
Eppendorf, Hamburg 
Eppendorf, Hamburg 
Scientific Industries 
Julabo 
 
21.24. Software 
- Adobe Design Premium CS2 
- Axio Vision Rel. 4.8 
- ImageJ 1.38x 
-LSM Image 
- Lasergene 
-Vector NTI 9.0 
-EndNote X4 
Adobe 
Carl Zeiss 
NIH 
Carl Zeiss 
GATC biotech 
Invitrogen 
Thomson Reuters 
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2.2 Methods 
2.2.1 DNA sequencing  
DNA sequencing was done either in cooperation with the sequencing service of the 
department of developmental biochemistry, GZMB, University of Göttingen or the 
sequencing serve from SeqLab, Göttingen. 
 
2.2.2 Extraction of Genomic DNA from a single fly 
The single fly was grinded in 30μl of buffer B with 200μg/ml proteinase K, then 
adding 2μl 10% SDS. The homogenized fly was incubated 1 to 4 hours at 37℃. After 
incubation, 3μl 3M NaCl was added, then the phenol/chloroform extraction was 
preformed with 1:1 volume. The aqua phase was transferred to new tube, and 50μl 
EtOH was added, and incubated on ice for 20min. The DNA was precipitated by 
centrifuging for 10 min at 14,000 rpm. The DNA was dissolved into 30μl TE buffer 
after washing with 70% EtOH. 
2.2.3 PCR 
PCR reactions were performed using Taq or Pfu DNA polymerase. For standard PCR 
reactions the following reagents were mixed: 50-200 ng DNA template, 0,4 μM forward 
and reverse primers, 50 μM dNTP (each), 10x PCR buffer (polymerase dependent), 1-2 
units (per 50 μl of reaction) Taq or Pfu polymerase. The reactions were performed under 
the following conditions:  
Step 1 (initial denaturation): 95°C for 1 min  
Step 2 (denaturation): 95°C for 30 sec  
Step 3 (annealing): 50-60°C (depending on the annealing temperature of the 
respective oligos) for 1min  
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Step 4 (elongation): 72°C for 1min per kb to be amplified  
Step 5: repetition of steps 2-4 for 30 times  
Step 6 (final elongation): 72°C for 7 min 
2.2.4. Quantitative real time polymerase chain reaction (QPCR) 
The quantitative real time polymerase chain reaction (QPCR) was performed with 
oligreen fluorescence. The primers against actin were used as internal control. 
2.2.5. Molecular Cloning 
The general method for molecular cloning was followed Sambrook, 2001 
(SAMBROOK and RUSSELL 2001) and the website of Grosshans‟ lab 
(http://wwwuser.gwdg.de/~jgrossh/method.html) 
 
2.2.6. Motif predication by MEME program 
The motif predication was performed on the MEME website (BUSKE et al. 2010) 
(http://meme.sdsc.edu/meme4_6_1/intro.html). The maximum number of motifs to 
find was set to 10, the length of motifs was from 6bp to 25bp. Other setting was as 
default.  
 
2.2.7. Antibody Staining 
Dechorionate embryos with 50-100% Clorox for 90 sec, then fix the embryos with 
the mix of 5ml 4% formaldehyde in PBS and 5ml heptanes for 30 min on the shaker 
(100-200 rpm). After fixation, remove the fix-reactant and add 5ml methanol. 
Devitellinize the embryos by shocking vigorously for 30 sec. The embryos without 
vitelline membranes would fall down. Suck the embryos and store in methanol at -20
℃. When doing the staining, rinse once with fresh methanol and wash with 50% 
methanol/PBST for 5 min. Rinse 3X PBST then wash 2X 5 min with PBST. Block 
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with 5% BSA, then add 1
st
 antibody and incubate overnight at 4℃. Rinse 4 times and 
wash 4 times of 15 min. Then Add 2
nd
 antibody and incubate for 1 hour at room 
temperature. After incubation, rinse 4 times and wash 4 times with PBST for 15 min. 
The embryos may be stained with DAPI (8mg/ml) for 2min. Wash 2 times with PBST 
for 5 min. Then lineup and mount on the cover slips with aqua-polymount. 
2.2.8 Preparation of antisense Dig-labeling RNA probe  
The plasmid containing the proper cDNA was linearized at the 5‟ end of the cDNA 
by a proper restriction enzyme. Setup the transcription reaction as following:  
-1μl DNA (linearised 1μg) 
- 2μl 10x NTP+Dig labeling mix 
- 2μl 10x transcription buffer 
- 2μl RNA polymerase (40U of SP6) 
- 1μl RNase inhibitor (20U) 
- 12μl DEPC-treated water 
Incubated at 37℃ for two hours, then, the DNA was removed by 15min DNase I 
treatment. The RNA is precipitated by adding 0.8 µl 0,5M EDTA, 2 µl 5M LiCl, 75 
µl ethanol (-20°C) and incubated at 4°C for longer than 30min , then the RNA is spun 
for 10min at 14,000 RPM and washed with 70% ethanol for 5min. The RNA is 
dissolved in 20μl DEPC-treated water and adjusted to 1mg/ml.  
 
2.2.9. In situ hybridization with alkaline phosphatase  
Dechorionate embryos with 50-100% Clorox for 90 sec, then fix the embryos with 
the mix of 5ml 4% formaldehyde in PBS and 5ml heptanes for 30 min on the shaker 
(100-200 rpm). After fixation, remove the fix-reactant and add 5ml methanol. 
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Devitellinize the embryos by shocking vigorously for 30 sec. The embryos without 
vitelline membranes would fall down. Suck the embryos and store in methanol at -20
℃. When doing the staining, rinse once with fresh methanol and wash with 50% 
methanol/PBST for 5 min. Rinse 3X PBST then wash 2X 5 min with PBST. Wash 
with 50% hybridization solution (hyb sol) in PBST for 10 min at room temperature. 
Then wash with 100% hyb sol for 10 min at RT. Prehybridization with 100% hyb sol 
for 1hr at 55°C or higher temperature. Meanwhile, prepare the probe. Add 2ul 
dig-labeled probe and 1ul tRNA into 20ul water boil for 5min then chill on ice, then 
add 200ul ice-cold hyb sol. Incubate the embryos in the hyb sol with probe at selected 
temperature overnight. Rinse 3 times with pre-warned hyb sol and wash 3 times for 
30min. Then rehydrate with series of pre-warmed hyb sol and PBST mixture: 80%, 
60%, 40% and 20%. Afterward, block for 30min with 5% BSA in PBST. Then 
incubate with Dig antibody at 1 to 1000 dilutions for 1hr. Rinse 3 times and wash 
4times for 15min with PBST. Wash 3 times for 5min with AP buffer. Incubate the 
embryos in 1ml AP buffer with 4.5 ul NBT and 3.5 ul BCIP until the signal becomes 
visible. Terminate the reaction with PBST and dehydrate with ethanol and incubate in 
100% ethanol for 20min to remove the non-specific staining. Then rehydrate with 
series of ethanol/PBST mixture with gradually increased concentration of PBST. The 
embryos are visualized together with DAPI for marking the nuclei. 
2.2.10. Isolation and fractionation of nuclei for EMSA 
1g embryos were collected, dechorionated and frozen in liquid nitrogen. 
Homogenize the embryos with buffer A. Spin the lysate for 10 min at 4,000 rpm, 
discard the supernatant and suspend the pellet gently in 1ml buffer A. Then put the 
nuclear fraction carefully on 2ml of buffer B in a 15ml tube. Spin for 10 min at 4,600 
rpm with swing-out rotor. Suspend the pellet in 200 μl, transfer to a new tube. Spin 
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and wash with buffer C twice. Spin and suspend the pellet in 500 μl high salt buffer, 
incubate for 1 min. Spin for 10min at 13,000 rpm at 4°C. Save the supernatant (high 
salt extract), and suspend the pellet in 500μl high salt buffer, and spin again 10min at 
13,000 rpm and collect the supernatant (high salt extract II). The nuclear protein 
extract was transferred to 2X binding buffer with buffer exchange column (PG-10) 
2.2.11. Prepare the radio-labelled DNA probe  
The probes were prepared with either T4 polynucleotide kinase or PCR (LANIEL et 
al. 2001). For end-labeling with T4 polyncleotide kinase, the complementary strands 
of oligos were mixed, heated 5°C above the melting temperature for 5 min, and let 
cool to room temperature. Place the double-stranded oligos at 4°C for 2 hr.  
Setup the phosphorylation reaction as below: 
ds-oligos                   5 μl (250ng) 
10X kinase buffer            5 μl 
[γ32]ATP                  3 μl (30 μCi) 
T4 polynucleotide kinase      2 μl 
Add ddH2O                 50 μl 
Incubate at 37°C for 2 hr 
The DNA probe was purified by the G-25 Sephadex column (GE Healthcare, 
Uppsala, Sweden) and adjust the concentration to 30,000 cpm/μl. 
For the PCR method, it was followed the common PCR protocol with 5 μl 6000 
Ci/mmol [α32]dCTP. The DNA probe was purified by the G-25 Sephadex column (GE 
Healthcare, Uppsala, Sweden) and adjust the concentration to 30,000 cpm/μl. 
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2.2.12. Electrophoretic Mobility Shift Assay (EMSA)  
The basic protocol is performed according to the common protocol with few 
modification (LANIEL et al. 2001). The nuclear protein extract was transfer to 2X 
binding buffer  
Nuclear extract        10.0 ul (in 2X binding buffer) 
DTT (20mM)          1.2ul 
ZnOAC (50um)        1.2ul 
Poly(dI:dC) (1mg/ml)   1.0ul 
KCl (1M)             2.4ul final:200mM 
MgCl2 (100mM)       0.6ul final: 2mM 
Probe                2.0ul 
Cold Oligos           3.6ul 
The DNA-protein interacting reaction was set up at 25 °C for 15min. The 
electrophoresis was performed with 6% polyacrylamide gel and 0.5X tris-glycine 
buffer at 10mA for 2.5hr. The gel is dried and illuminated with Imaging plate 
BAS-MS 2040 (Fujifilm) and FUJIFILM FLA-3000 Image Reader. 
2.2.13. Western Blotting 
The staged embryos were collected on the apple juice plate, and dechorionated with 
bleach, then weighted and frozen in liquid nitrogen. The embryo were homogenized 
in 2X Lämmli buffer with the volume to make the final concentration 20embryos/μl 
(100embryos=1mg). Boil for 5 min 
The protein extracts were loaded on the SDS page. Run the page at 15 to 25mA for 
1hr. The protein was transferred to the membrane with wet transfer method for 3 hr at 
110V. Use 5% milk for blocking for 30min. Then incubate the membrane with first 
antibody at 4°C overnight. Wash the membrane 6 times with PBT for 7min each, then 
incubate it with 2nd antibody at RT for 2hr. Then wash 6 times with PBT for 7min each. 
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Soak the membrane with the reagent for peroxidase for 1min. then illuminate the film in 
the dark room. 
2.2.14. Isolation of total RNA and cDNA synthesis   
Total RNA was isolated from 10mg staged Drosophila embryos using 500μl 
TRIzol reagent. Homogenize the sample, then incubate at RT for 5 minutes. Add 
100μl chloroform and shake for 15 sec, incubate for 2-3 min at RT. Centrifuge at 
12000g for 15 min at 4°C. Transfer the aqueous phase to a new tube. Add 250μl 100% 
isopropanol and incubate at RT for 10min. Centrifuge at 12000g for 10 min at 4°C. 
Wash with 75% ethanol and dry the RNA pellet. Dissolve the RNA in DEPC-treated 
water and adjust the concentration to 1 ug/μl. 
cDNA synthesis was performed with Reverse Transcriptase, Oligo-d(T) and 1 μg of 
RNA as template in a final volume of 20 μl. The cDNA was subsequently used as 
template for PCR. 
2.2.15. Generation of Germline Clones 
The germline clone was performed following the instruction by Chou and Perrimon 
(CHOU and PERRIMON 1992) with minor modifications. The heat shock for inducing 
flippase was performed at 37°C for 90min per day for two days after hatching.  
2.2.16. Injection of α-amanitin into embryos 
The injection of α-amanitin, RNA polymerase II inhibitor, was performed 
following the instruction by Schubiger and Edgar (SCHUBIGER and EDGAR 1994). The 
concentration used was 500μg/ml. The injection was performed in embryos of 0 to 30 
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minutes. The embryos were placed in S10 hydrocarbon oil for one hour, then recorded 
under spinning disc microscope. 
2.2.17. Generating Transgenic flies 
The transgenic flies were generated with either P-element transposon system and a 
φC31-based integration system (ASHBURNER 1989; BISCHOF et al. 2007).  
For the P-element transposon system, mix 3μg DNA of target genes on pCasper4 
vector with 1μg of pDelta2-3 turbo vector and perform the ethanol precipitation and 
dissolve in ddH2O to the concentration of 0.8 μg/μl.  
The embryos of w or yw were collected from the apple-juice plates, lined up on agar 
plate and transferred to a glass slide, dried for 10 min, then covered by hydrocarbon oil 
(Voltalef H3S, ARKEMA, France). The DNA was injected with a glass needle at the 
posterior end of the embryos. Then leave the injected embryos at 18ºC for 48 hr. 
Transfer the larvae to a new food vial with the needle. After eclosion, collect the adult 
flies and cross them with the double balancers. Select the F1 flies with eye color and 
cross them with double balancers. Decide which chromosome the transgene is by 
linkage with the dominate markers of F2 and setup stocks. 
ForφC31-based integration system, the transgenes were inserted into the attB 
vectors. The embryos of attP-zh86Fb/nos-φ-zh102D (integrated at 3rd chromosome) 
were used for injection. The transgenetic flies were selected by eye color and setup 
stocks as the P-element inserted transgenetic flies. 
 
2.2.18. Mapping with duplication and deficiency 
All the genomic and sequence data of Drosohpila melanogaster is from the Fly 
Base (http://flybase.org/) (TWEEDIE et al. 2009). 
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For the complement test with duplications, the mutant females were collected and 
crossed with the males containing the molecular defined duplication either attached 
on 3rd chromosome (POPODI et al. 2010) or attached on Y chromosome (COOK et al. 
2010). The male progeny was collected. If the mutant male progeny with duplication 
is viable, it means the duplication line can complement the mutation, and the mutation 
is located within the region of duplication.  
For the complement test with deficiencies, the mutant females were first crossed 
with the males with complemented-duplication on Y chromosome. Then the viable 
mutant male progeny was collected and crossed with the females from deficiency 
lines. If the mutant/deficiency females are lethal and can not be found, the deficiency 
can not complement the mutation. It means the mutation is located within the region 
of the deficiency. 
 
 
2.2.19. Mapping with Single-Nucleotide Polymorphism (SNP)  
The general procedure and strategy followed the instruction from Berger, et al 
(2001) and Chen, et al(2007) and is illustrated in figure (BERGER et al. 2001; CHEN et 
al. 2008). The SNP were obtained by the direct sequencing of specific region on X 
chromosome between stocks w X161 f FRT
18E
/FM7, FM7c/FM7c, FM7h/FM7h, y pn 
cv v FRT
18E
(B437) and w sn neoFRT
19A
(Table). The genomic DNA of single 
recombinant fly was extracted and used as the template for PCR and sequencing 
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Table 1 : The Summary of SNP used in this study. The primers in bold are using as primers for sequencing 
Number Cyto resion position X161 B437 FRT19 FM0 FM7h Left flank Right flank PCR primers  
1 9F 10816046 A G G G G CAATCATCCCATACCACCCA TCATCTCACCTAGTCGATAG HS196/HS197 
2 9F 10816060-1 CT TC TC TC TC CACCCAGTCATCTCACCTAG GATAGAGTTACCATTTAAAT HS196/HS197 
3 11A 12373767-8 -- CT CT CT CT GATTACCATCTTATACTACT ACACATACCGTTTTTAGTCA HS194/HS195 
4 12A 13444753 A T A A A TATTAAAACGCCCATTTAAG CCATTTCTTTCAGTGCTCCC HS179/HS178 
5 12A 13444671 A C A A A ACATACCTACCCACATCTCA ATATACCCTTCTATGCTAAG HS179/HS178 
6 12A 13444662 C C C C C AGCTGTTACATACCTACCCA ATCTCAGATATACCCTTCTA HS179/HS178 
7 12A 13444641 T G T T T TTTTTTATAAATGCCACACC AGCTGTTACATACCTACCCA HS179/HS178 
8 12D 13801573 A G G G G TGCCACCTACAATATGTATG CTTAGGTGTCGCCTTTGTGG HS161/HS162 
9 12D 13801916 C T C C C TTAAATTAGATGCCCATACA ACAAAACAAAACGAGATCAG HS161/HS162 
10 12D 13801921  G A G G G TTAGATGCCCATACACACAA ACAAAACGAGATCAGCCGCC HS161/HS162 
11 13A 14862598 T G G G G ATCACCATCTCCGCATCTCC CATCTCCTCATCTGCGGACG HS165/HS164 
12 13A 14862463 A T T T T TTAATTATATGCATTAAAGG ACTGGGCAGAGAGGCAGCAG HS165/HS164 
13 13A 14862200 G A A A G TCGGGTAATACGACTTTAAA CGTTACAATAAGCTCGTTTA HS165/HS164 
14 13F 15755025 G A A A A TTCCTCTTTTTTTTTAGTAT CCATCCCATCCGCGAGATAA HS183/HS182 
15 14B 16048476 A C A A A GCCGCTTTAATTACAAAACG AAGAAGTCAAATTACTAGCC HS202/HS203 
_____________________________________________________________________Results 
58 
 
3. Results 
3.1 The genomic regulatory elements of frs  
3.1.1 The conservation of the promoter region of frs 
The N/C ratio is the key measurement for the size of cells amd paly an important 
role controlling the number of cleavage cycles (UMEN 2005). N/C ratio is also a factor 
controlling the expression of some zygotic genes. However, how cell senses the N/C 
ratio and hoe N/C ratio mediates the transcription remains unknown. To fullfall this 
gap, we investigated the genomic regulatory elements of frs, one of the known genes 
whose expression was respond to N/C ratio (GROSSHANS et al. 2003). 
We first used the bioinformatic approach to predict the possible genomic regulatory 
elements. Based on the blast of frs protein sequence against the translated nucleotide 
database, frs orthologs can be found only in Drosophila genus, but not in the genome 
of two mosquitoes, Anopheles gambiae and Aedes aegypti. The sequence comparison 
of frs genomic region revealed that -500 to 0 bp upstream of the frs transcription start 
site showed a high similarity (75%, figure 9A), even higher than the coding region of 
frs. This high conservation suggested that the regulatory elements of frs may locate in 
this region. 
 
3.1.2 The frs promoter-driven GFP reporter construct  
In order to investigate the genomic regulatory elements, we generated the EGFP 
reporter construct driven by the 1.3kb genomic sequence between frs and the 
upstream gene, cg7841 (frs1.3::GFP). The transgene containing the genomic fragment 
including this 1.3 kb region and frs gene can fully rescue the frs mutant, therefore it is 
considered to contain full genomic regulatory modules for frs expression (GROSSHANS 
et al. 2003). In our repoter construct, we replaced the frs coding region to EGFP, and 
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add the 3‟UTR region from heat shock protein 70, which enhances the translation. 
The other region, including transcription start site, 5‟UTR, promoter region and 
upstream region were from frs genomic DNA and was identical as endogenous frs 
locus. 
The GFP expression of frs1.3::GFP can fully represented the endogenous frs 
expression (Figure 10 B and C). The expression started in early cycle 14 of wild type 
embryos. In maternal haploid mutant embryos, the peak of expression was in cycle 15. 
This result indicated this reporter system could reflect the expression of frs and can be 
used for the further analysis. This result also suggested that the genomic regulatory 
element located within this region. 
 
 
 
Figure 9: The summary of the motifs in 500bp upstream region of frs gene. (A) the graph of 
the sequence similarity for the sequence alignment of 500bp upstream region of 12 frs 
orthologs. The sequence conservation is 75% by Align X (Vector NTI). (B) the conserved 
motifs predicted by MEME program. The predicted motifs are mainly located with 300bp 
upstream of frs coding sequence. The arrangement of the motifs is identical in melanogaster 
and obscura group. The motif 3 and 10 represent the transcription start site (TSS). 
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Figure 9(continued): The sequence alignment of upstream region of 7 frs orthologs in 6 
species in melanogaster group(C). The violet box marks the protein-binding region found in 
EMSA. The orange boxes mark the two motifs which prevent premature expression in 
reporter assay. The blue boxes mark the predicted motifs which were substituted in the 
reporter assay and gave no change of expression. The pick and green box mark TAGteam 
motif and TATA box respectively. The transcription start site (TSS) is at the end of the 
sequence. D_m: D. melanogaster, D_s: D. simulans, D_a: D. ananassae, D_p: D persimilis, 
D_e: D. erecta, D_y: D. yakuba. There are two frs orthologs in D. yakuba due to the genome 
duplication during evolution. 
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Figure 10: The GFP reporter construct can represent the endogenous frs expression. (A) the 
diagram of the reporter construct. The full length of intergenetic region is placed upstream of 
GFP coding sequence, flanking by the 3‟UTR of HSP 70. The in situ hybridization of GFP 
starts at cycle 14 in diploid embryos (B) and at cycle 15 in haploid embryos (C). 
To narrow down the minimal regulatory region, we generated more reporter 
constructs with shorter genomic upstream sequences. The frs260::GFP with 260bp 
upstream region could fully drive the frühstart expression (Figure 11C). However, the 
expression of the frs180::GFP was greatly reduced and there was no signal in 
frs100::GFP (Figure 11B). This 260bp region is sufficient to drive frs expression and 
the region between -260bp to -180bp may be required for the expression of frs. To 
further narrow down this region, three deletion constructs, Δ(-265 to -215)::GFP, 
Δ(-216 to –q76)::GFP and Δ(-265 to -176)::GFP at this region were generated. 
However, no expression was detected in these three reporters. 
One possibility is that the enhancer which directs the frs expression is deleted in all 
of these constructs. However, it is also possible that the proper spacing between the 
promoter and the enhancer was disturbed. The deletions are at 150bp upstream of 
transcription start site, and since the average sequence to form a smoothly graded 
bend is about 200bp. The result of deletion construct may due to the shortening of the 
space but not the deletion of the enhancers.  
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Figure 11: The prom 260 is the minimal genomic regulatory region for frs expression. (A) the 
summary of the reporter with different length and deletion. The reporter with promoter region 
shorter than 180bp gives no expression (B). The expression of prom 260::GFP show similar 
expression profile as endogenous frs in both diploid and haploid embryos (C and D).  
 
 
 
3.1.3 The substitution constructs 
To avoid disturbing the spacing between the promoter and transcription factor 
binding site, we changed our strategy. Instead of making deletion constructs, we 
generated a new set of reporter constructs with short substitutions within frühstart 
genomic regulatory region. We used the MEME program (BAILEY and ELKAN 1995) 
to predict conserved motifs in these 330 bp region (Figure 9B and C). Based on this 
prediction, we made short substitutions (from 6 to 15bp) within this region, including 
TAGteam motif (CAGGTA) which was showed to be the enhancer for early zygotic 
activation (LIANG et al. 2008).  
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Among our 7 substitution constructs (Figure 9C and 12), two constructs 
prom(-68--57)::GFP (motif: GATATTTATGGC) and prom(-174--161)::GFP (motif: 
CATTAAAAAGGGATT ) show the premature expression at cycle 13 in wild type 
embryos (Figure 12). In haploid background, the expression could be detected as early 
in cycle 13; however, the majority signal was at cycle 14 (Figure 13). Although the 
expression of these two constructs starts prematurely, it still delays in haploid 
embryos.  
 
Figure 12: Summary of the motif-substitution reporters. The substitution of two motifs 
prom(-68--57)and prom (-174- -161) (grey box) leads the premature expression at 
cycle 13 in diploid background, however, in haploid embryos, the expression starts at 
cycle 14 in haploid, which is one cycle later than in diploid.  
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Figure 13: two motifs (-68--57) and (-174- -161) prevent the frs expression at cycle 13. 
A and B, in situ of GFP in ss(-68--57)::GFP.  
C and D. in situ of GFP in ss(-174- -161)::GFP  
E and F, in situ of GFP in ss(-127--121)::GFP.  
G and H. in situ of GFP in ss(-106--99)::GFP 
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3.1.4. The -260 to -211bp upstream region is a preotin binding motif 
In order to investigate the DNA-protein interaction in frs promoter region, the 
electrophoretic mobility shift assay was preformed. Two different p
32
-labeled PCR 
products covering -279--110bp upstream region were used as probes. The nuclear 
extract from 0.5-1.5 hr embryos were used to identify the specific DNA-protein 
interaction prior or in the early cellularization. There was a strong shift of the 
-279--110bp DNA fragment with the 0.5-1.5 hr extract and the shift pattern was 
changed to two lower shifts (Figure 14). 
 
Figure 14: One DNA-protein interacting motif locates at -279bp to 211bp upstream of frs. 
The probe (-279 to -110 bp upstrem of frs gene) wass generated by PCR. One specific shift 
was obtained with nuclear extract of 0.5 to 1 hr embryo.  
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To further narrow down the protein interacting motifs and confirm the specific 
interaction, the non-labeled double-stranded oligos were added to compete the 
interaction with probes. Two oligos -260--231 and -240--211 could compete the 
DNA-protein interaction with dose-dependent manner (Figure 15). Thus, a protein 
interacting region was mapped to -260 to -211 upstream of frs gene (Figure 9C).  
 
Figure 15: The cold oligos competed to the shift in dose-dependent manner. Two oligos -260 
to -231bp and -240 to -211bp can compete to the radio-labeled probe in dose-dependent 
manner. However, the oligos of flanking sequence did not compete to the shift. 
 
In summary, I narrowed down the functional frs regulatory region to 260bp 
upstream region. The -260bp to -180bp is required for the expression of frs and also 
showed a specific DNA-protein interacting. Secondly, I identified two motifs,  
GATATTTATGGC and CATTAAAAAGGGATT, which prevented the premature frs 
expression at cycle 13. However, I didn‟t find the elements, which responds to N/C 
ratio. 
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3.2. The Genetic Analysis of RPII215
X161
 
3.2.1 X161 germline clone undergoes only 12 nuclear divisions 
To gain further insight for Drosophila development, one EMS-inudced mutagenesis 
was performed in Tübingen (VOGT 2006; VOGT et al. 2006). Previous in our lab, a 
genetic screen with this EMS-mutant collection was perfoermed in order to identify 
the candidate maternal genes required for the early Drosophila screen. The mutants 
were seleced for the defects observed by the DIC time-lapse imaging. One mutant, 
X161, on X chromosome, showed the premature entry of the cellularization with 
lower nuclear density (Figure 16A).  
 
Figure 16: X161 GLC embryos undergo one division less. (A) Half number of cells in stage 6 
X161 GLC embryo compared to wild type. Green: Kuk, Orange: Eve. (B) Bar graph showing 
the penetrance of cell cycle phenotype in X161 GLC. 40% of X161 GLC 
 
Live imaging with differential interference contrast microscopy (DIC) and 
fluorescence imaging with histoneRFP confirmed the reduced number of nuclear 
divisions. The result showed that 40% of embryos had one division less than the wild 
type (Figure 16B and Table 2). 10% of the embryos are patched embryos with mixed 
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territories of nuclei in cycle 13 and cycle 14. The remaining 50% of embryos 
underwent the normal number of divisions. Despite the normal number of nuclear 
division in these embryos, the interpahse of cycle 13 in the X161 GLC with 13 
nuclear divisions was extended to about 20 min at 21°C, compared to 12 min in wild 
type (Figure 17 and Table 3). In patchy embryos, the interphase 13 is further 
prolonged to more than 30 min. The length of the interphase and mitosis of cycle 11 
and 12 was not different to wild type.  
Table 2: Summary of the number of cleavage cycles in different background. 
 
number of nuclear divisions 
 
Genotype/cross 12 12patchy 13 13patchy 14 
Wild type 0 0 128 0 0 
X161 FRT
18E
 /FM7 0 0 46 0 0 
X161 FRT
18E
 GLC 24 5 27 0 0 
haploid X161 GLC 16 3 11 1 5 
RPII215
X161
FRT
19A
 
GLC 
4 5 15 0 0 
2X Dp(1;3)DC241 0 0 16 0 0 
X161/X161; frs/frs 36 11 48 0 0 
WT +water 0 0 34 0 0 
WT +α-amanitin 0 0 2 0 21 
RPII215
X161 
+water 11 7 12 0 0 
RPII215
X161 
+α-amanitin 
0 0 21 0 0 
The X161 FRT18E refers to the original X161 line which contain two mutations 
on X chromosome. The RPII215X161FRT19A refers the “cleaned” X161 line which 
only was recombined with viable marker chromosomes distal and proximal to 
RPII215
X161
. 
 
The mutant embryos went into the normal cellularization and gastrulation, even 
with fewer cells. The seven eve stripes in the X161 GLC suggests anterior-posterior 
patterning is not affected. The proper morphology of the ventral furrow suggests that 
the dorsal-ventral patterning is correct during gastrulation (Figure 16A). Since there 
were few larvae hatched (>1%), further defects may occur during later embryonic 
stages in addition to the reduced cell number in helf if the embryos. We did not 
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investigate these potential phenotypes. 
 
Figure 17: length of interphase and mitosis in wild type and X161 GLC. The interphase 13 of 
X161 is significantly longer than in WT (P<0.05). The lines represents the length of 
interphase, the column represents mitosis. The number below the line indictes the time (min). 
WT is in blue and X161 is in red. 
 
Table 3: The time length of nuclear division after cycle 10 
  Divisions 
embryos  10I 10M 11I 11M 12I 12M 13I 13M 14I 
cellularization 
WT      (n:18)  3.4±0.9 6.5±1.1 4.5±1.0 7.7±0.9 6.5±1.1 8.3±1.0 12.8±2.3 9.1±2.5 57.1±4.4 
X161 13   ( n:8)  4.3±0.9 6.3±0.9 
5.5±1.0 6.25±0.4 8.1±1.9 7.5±0.9 20.2*±2.3 7.78±2.25 55.4±8.7 
X161patchy (n:3)  3 6 3 6.7±0.5 10±2.0 7.0±0.8 32.6*±4.4 9.2±1.5 48.2±9.5 
X161 12   (n:3)  3 7 4±1 7.0±0.8 13±4.5 9.0±1.4 66.0±12.0   
The unit of time is minutes, the number after “±” indictes the standard deviation. 
 
 
3.2.2. X161 does not affect the cell cycle  
 The premature stop of the mitosis in X161 may be due to the complete arrest of 
cell cycle machinery. Alternatively, the mutation of X161 may only affect the timing 
and the number of the cleavage divisions. To test these two possibilities, following 
experiments were performed.  
In previous studies, it is showed that the premature arrest of nuclear divisions often 
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leads to the uncoupling of the DNA duplication and the centrosome duplication 
(MCCLELAND and O'FARRELL 2008). If this phenomenon happened in X161 mutant, 
there would be more than 2 centrosomes per nuclei. However, antibody staining for 
γ-tubulin revealed that there were two centrosomes per nuclei during interphase 14 in 
X161 (Figure 18 C). Despite the correct pairing of the centrsome cycles, we observed 
that the distance between the pairs of centrosomes was longer in X161 GLC embryos.  
The result clearly shows that there is no extra centrosome duplication in X161 GLC 
embryos.  
 
Figure 18: Centrosome cycle is not affected in X161.There is no extra centrosome duplication 
in X161 GLC after cell cycle stop (D to F) as in wild type (A to C). The embryos were in late 
cellularizaion, but X161 GLC was at cycle 13 while wild type was at cycle 14. γ-tubulin 
marks the centrosomes in green, DAPI marks DNA in blue, the scale bar: 10μm 
 
Following cellularization, the mitosis 14 occurs in an asynchronous manner in 25 
different domains. With few exceptions, cells enter mitosis according to the 
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expression of string (EDGAR et al. 1994a; FOE 1989). To test whether the timing and 
patterning of mitosis 14 is affected by X161, we preformed the in situ hybridization of 
string and the staining with the mitotic marker, pospho-Histone H3 (S10) antibody 
(HAU et al. 2006). The expression of string was generally similar to wild type. The 
mitosis always occurred in the region where string is expressed (Figure 19 B and C). 
In embryos with patches, we observed higher expression level of string in the patches 
with lower nuclear densities. This may be due to the longer period of time after exit 
from mitosis 13. We also noticed that the mitotic pattern was slightly advanced as 
compared to the gastulation movement (compare Figure 19 A and C) as it is also seen 
in trbl and frs mutants (GROSSHANS and WIESCHAUS 2000). To summary, X161 
specifically affected the counting mechanism of the nuclear divisions, but it did not 
disturb the general cell cycle mechanism. 
Figure 19: The mitosis 14 occurred according to the mitotic domains in wilde type (A, B.) 
and X161 embryo(C, patchy, D, the same stage as A). Arrowhead indicates the mitoic cells at 
cephalic furrow. Arrow indicates the ectopic mitosis at head region in X161. pHS3 (S10) 
staining marks the cells at mitosis, in situ of stg marks the mitotic domain.  
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3.2.3. The X161 mutant does not affect the ploidy of the nuclei. 
Since the number of cleavage cycles is controlled by the N/C ratio. It is possible 
that the premature stop of cell cycle in X161 mutant is due to tetraploidy of the 
embryos. To test this hyphosis, we stained for CID protein. CID is the Drosophila 
homologue of the CENP-A centromere-specific H3-like protein which localizes at 
centromeres (BLOWER and KARPEN 2001), allowing to count the number of 
chromosomes in one cucleus. There are 8 dots of CID staining in each X161 nucleus 
during interphase similar to wild type (Figure 20). It indicated that the chromosome 
number and ploidy is not affected in X161 embryos.  
 
Figure 20: X161 GLC embryos contain normal set of chromosomes in wild type (A, B, C), or 
in X161 (C, D, E). Notice that the cell density of X161 is less than in WT. Centromeres are 
marked by CID, DNA/nuclei are marked by DAPI. Green: CID, blue: DAPI, scale bar: 20μm. 
3.2.4. The X161 phenotype in haploid embryos 
Haploid embryos undergo an extra mitosis before cellularization (EDGAR et al. 
1986), which is opposite to the phenotype of X161, allowing to establish genetic 
epistesis. Such embryos were produced by crossing females bearing X161 germline 
clones with male homozygouses for ms(3)K81. Ms(3)K81 prevents the union of 
maternal and paternal prenuclei but still allows development to continue with haploid 
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maternal genome (YASUDA et al. 1995). The haploid X161 embryos undergo viable 
number of nuclear divisions. The embryos at cycle 13, cycle 14 and cycle 15 could be 
observed (Figure 21B and Table 2).. One patchy embryo even contained three 
compartments of different nuclear density (Figure 21A). This result indicated that 
X161 and haploid are not epiststic to each other, and suggests that they act in distinct 
processes to control the cell cycles. 
 
Figure 21: Epistasis of X161 and haploid mutants. X161 and N/C ratio work in in parallel to 
control the number of nuclear divisions. The haploid X161 GLC show complicated patched 
embryos (A). The number of nuclear divisions in haploid X161 embryos is summarized in (B). 
About 50% of haploid embryos undergo 12 nuclear divisions, 34% undergo 13 divisions and 
15% undergo 14 divisions.  
3.2.5. Partial rescue of the phenotype by zygotic activation 
Since only half of the embryos had a reduced number of nuclear divisions, X161 
may show a zygotic rescue. To test this hypothesis, X161 females were crossed to 
males with a marked X-chromosome (FM7c, P{ry[+t7.2]=ftz/lacZ}YH1) (KLÄ MBT et 
al. 1991). Zygotically heterozygous (female) embryos therefore could be separated 
with hemizygous males by the staining of β-galactosidase to mark the female. The 
embryos at stage 5 and 6 were collected and checked for nuclear density from both 
male and females. 87% of the male embryos showed the premature stop of nuclear 
division, compared with the female (52%) (Table 2). Although there was still 50% of 
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females show the phenotype, the male has higher portion of defect. It suggests there is 
a partial rescue for the premature stop, but not fully. This result also confirms that the 
extension of lengeh of interphase 13 in all the X161 embryos is a strictly maternal 
phenotype.  
3.2.6. Cellularization occurs immediately after cell cycle stop 
In wild type, cellularization immediately starts after exit mitosis 13. To test whether 
such a link is also observed in X161 embryos with premature stop of cell cycle, we 
used time-lapse imaging with Moesin::GFP to visualize the progression of 
cellularization. Unlike the result of cyclin RNAi treatment (MCCLELAND and 
O'FARRELL 2008), cellularization in X161 mutant started after last mitosis (Figure 22). 
The progression of cellularization in interphase 13 is 10min slower than in interphase 
14. Since the average time of cycle 13 is 36 min, it is unlikely that cellularization 
starts at an absolute time after fertilization. However, inhibition of the cell cycle was 
not sufficient to forestall cellularization, which is based on the experiment of RNAi 
against mitotic cyclins (MCCLELAND and O'FARRELL 2008). We proposed that the 
difference result of these two experiments is due to the premature activation of 
zygotic genome in X161.  
 
Figure 22: The cellularization occurred immediately after last mitosis. (A) is wild type at 
cycle 14 and (B) is X161 embryos at cycle 13. The movie was obtained with meosin::GFP to 
mark the furrow cancal. Scale bar is 20μm. 
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3.2.7. X161 causes premature degradation of cdc25 homologs 
The degradation of the maternal transcripts cdc25 homologs, string (stg) and twine 
(twn), plays an important role in proper stop of cell cycle (EDGAR and DATAR 1996). It 
is possible that the degradation of stg and twn is changed in X161 mutant. In wild 
type embryos, the maternal transcripts of stg and twn are abundant until the 
mid-cellularization in interphase 14. In the embryos with premature stop, the 
expression of stg and twn disappeared in mid-cellularization of cycle 13 (Figure 23). 
Since degradation of stg and twn followed the premature onset of cellularization in 
interphase 13, the degradation may be the consequence but not the cause of the 
premature stop of nuclear division. Althogu we did not perform a genome-wide 
analysis, it is quite likely that some other maternal transcripts, if not all, may be also 
degraded prematurely in X161 mutants.  
 
Figure 23: Expression of stg and twn. The in situ hybridization of stg (A) and twn(B) in WT 
and X161 embryos. The cycle is decided by the nuclear density. The furrow canal is marked 
by the immunostaining agains Slam. Scale bar: 10μm as all the following nuclear density 
pictures. 
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3.2.8. X161 causes premature expression of zygotic genes 
The stop of nuclear divisions and onset of cellulariztion require the zygotic gene 
expression (EDGAR and DATAR 1996). The embryos injected with the RNA 
polymerase II inhibitor, α-amanitin, do not cellularize and undergo one extra nuclear 
division. This data suggested that zygotically expressed mitotic inhibitors are 
involved in pausing the nuclear division at cycle 14. At least two mitotic inhibitor 
tribbles and frühstart have been identified (GROSSHANS et al. 2003). Expression of 
mitotic inhibitors is sufficient to pause the cell cycle. 
To test whether the premature stop of cell cycle in X161 is due to the premature 
expression of zygotic cell cycle inhibitors, the expression profile of frs was analysised 
by in situ hybridization. In wild type, the major peak of frs expression showed up at 
early interphase 14 (Figure 24A). In X161, the peak of frs expression is at interphase 
13 (Figure 24B). We concluded that the expression starts one cycle earlier, 
immediatedly following the exit of mitosis 12. 
Since cellularization starts immediately after mitosis 12 in half of X161embryos, 
the zygotic genes, which are required for cellularization, may be expressed 
prematurely as well. Therefore, we analysised expression of slow as molasses(slam). 
Slam is required for the slow phase of cellularization (LECUIT et al. 2002). In wild 
type, the expression of slam starts at late interphase 13 and has the major peak at early 
cycle 14. The expression of slam was detected as early as interphase 12 in X161 
embryos (Figure 24C and D). It may be the reason why the cellularization can occur 
prematurely in the X161 embryo but not in other mutant embryos.  
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The microarray comparison between diploid and haploid embryos revealed that 
there are two clusters of zygotic genes, N/C dependent and N/C independent (LU et al. 
2009). Frs belongs to the N/C dependent cluster and slam belongs to the N/C 
independent cluster. Both frs and slam are expressed prematurely in X161 mutant. 
This suggests that onset of zygotic gene activation is affected in X161 embryos. 
3.2.9. The X161 frs double mutant could not rescue premature cell cycle pause 
It is showed that the premature stop of cell cycle in X161 mutants requires the 
zygotic activation. frühstart is a good candidate of the zygotic gene that mediates the 
inhibition of cell cycle. Frs is the cell cycle inhibitor which blocks the subtract 
binding site (hydrophobic patch) of cyclin (GAWLINSKI et al. 2007) , and its 
expression is precisely at early interphase 14 in wild type embryos (GROSSHANS et al. 
2003). However, the expression of frs could be detected as early as in interphase 12 in 
Figure 24: Expression of frs and slam. The in situ 
hybridization of frs (A, B) and slam(C, D) in WT and 
X161 embryos. The cycle is decided by the nuclear 
density . 
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X161 mutant. It is possible that X161 pauses the cell cycle via regulating the 
expression of frs. To test this possibility, X161, frs double mutant was generated. The 
penetrance of the double mutant was as the same as X161 alone. It suggested that frs 
was not required for pause of cell cycle in X161. This is consistent with the previous 
result that frs is only one of several zygotic mitotic inhibitors (GROSSHANS et al. 
2003). In summary, frs may be involved in the premature stop of cell cycle, but there 
are redundant cell cycle inhibitors. Therefore, frs alone is not required for the 
premature entry of MBT. 
3.2.10. The premature cell cycle pause requires the expression of zygotic genes 
Since we observed the premature expression of zygotic genes, the question was 
reaised whether zygotic expression is required for the cell cycle phenotype. One 
possibility is that X161 affected the cell cyele directly, or by maternal cell cycle 
regulators, such as CycB and grapes (EDGAR 1995; SIBON et al. 1997). The other 
possibility is that X161 cause the premature stop of cell cycle via the expression of 
zygotic genes (Figure 25A). To distinguish these two hypotheses, the expression of 
zygotic genes was blocked by the injection of α-amanitin, inhibitor of RNA 
polymerase II, is performed. If the expression of zygotic genes is required, the 
injection of α-amanitin would revert the cell cycle phenotype to 13 or 14 nuclear 
divisions. The result showed that all the injected X161 germline clone embryos 
underwent at least 13 nuclear divisions, while 50% of the embryo injected with water 
still underwent 12 divisions. The result suggested the zygotic activation is required for 
the premature stop of cell cycle in X161 GLC embryos (Figure 25C). In wild type 
embryos, the injection of α-amanitin cause an extra mitosis. However in X161 embryo 
(Figure 25B), the injection of α-amanitin also caused severe nuclear fallout and 
nuclear fusion (Figure 25 E and F). Therefore, the further imaging could not be 
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recorded. 
 
Figure 25: X161 requires zygotic gene expression. (A) summary of the predicted results of 
α-amanitin injection. (B) α-amanitin caused extra cell cycle in wild type (93%). (C) 
α-amanitin rescued the premature cell cycle stop phenotype of X161 GLC. Theα-amanitin 
cuased the moderate nuclear fallout and fusion (E) and severe fallout and fusion in X161 (F), 
which was not occurred whe injected with water (D) 
3.2.11. Isolation of X161 genes 
The initial approach to map x161 was the complement test with the X-chromosome 
duplication kit. However, no duplication could complement the lethality of X161 
(table 4). There are gaps in the duplication kit, although it covers more than 90% of X 
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chromosome, It is possible that X161 is within one of these gaps. Another possible 
explanation is that there may be more than one lethal mutations on X161 X 
chromosome. 
To narrow down the position of X161, the linkage map of meiotic recombination 
was performed with a marker chromosome carrying visible markers (Figure 26). The 
lethal mutation locates between vermilion (cytomap: 33.0) and forked (cytomap: 56.7). 
With the calculation using the recombination between white and crossveinless as 
reference, the genetic distance between crossveinless and the mutant is 30.3 cM and 
between forked and the mutant is 9.5. The calculation from the proximal and distal 
markers estimated the position of the mutation at at 44 to 47 at the recombination map, 
which is roughly at 12 to 13 in the cytological map. 
Table 4: the complement test of original X161 line with duplication kit 
Number Duplication Bar male WT male 
901 1Lt--2B18 66 0 
761 1A3--3A2 173 0 
1527 2C1--3C5 121 0 
936 2D2--3D3 146 0 
1319 3C1-2;3E7-8 111 0 
5594 
3C2;3F + 3F;4E3 + 
4E3;5A1-2 
146 0 
5279 4C11;6D8 + 1A1;1B4 (Dp) 91 0 
948 6C;7C9-D1 116 0 
1879 7A8--8A5 64 0 
5678 
7D;8B3-D7 + 16A1;16A1 + 
20B;20Fh 
53 0 
5292 8C-D;9B + 1A1;1B2 122 0 
929 9A2;10C2 143 0 
5596 1A1;1B1-2 + 10C1-2;11D3-8 187 0 
3560 
9F4;10E3-4 + 1A1;1B2 + 
20B;20Fh 
114 0 
5459 11D--12B7 170 0 
3219 
12A6-10;13A2-5 + 
1A1;1B3-4 
134 0 
5273 
13F1-4;16A1 + probably X 
tip segment 1A1;1A 
98 0 
1537 15B1--16F 148 0 
1538 
16F1-4;18A5-7 + 1A1;1B2 + 
19E5-7;20Fh 
110 0 
3033 18F1;20Fh + 1A1;1B2 160 0 
940 3D6-E1;4F5, 4E3;5A1-2 178 34 
5281 5A8-9;6D8 145 0 
1527Pr 2C1;3C5 117 1 
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3.2.12. Mapping with Single nucleotide polymorphisms and chromosome 
cleaning 
To further narrow down the X161 mutation, the mapping with SNP was performed. 
X161 flies crossed with the marker line, y, pn, cv, v, f, FRT18E, and the recombinants 
were collected and checked for SNPs. 
 
Figure 26: Mapping of X161 by meiotic recombination. The summary of the meiotic 
recombination between w
-
, X161, f, FRT18E (blue) and the marker chromosome y, pn, cv, v, f, 
FRT18E (orange). The number indicated the F1 progeneies of specific genotype. The blue 
dash line illustrates the approximate region X161 mutation locates. The blue line indicates the 
region from mutant chromosome, the orange, from the marker chromosome. 
5 of 48 v
-
 f
-
 viable males show the SNP from X161 at 11A and SNP from B437 at 
9F. This result narrowed the location of the mutant down to 9F to 11A (Figure28A). 
However, the 7 of 13 lethal female recombinants (distal: marker and proximal: mutant) 
contained the marker SNP at 11. This result suggested that there was another mutation 
was proximal to 11 which was inconsistent with the result from the male 
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recombinants.  
To explain this conflict result, I assumed that there may be two mutations on the 
X161 chromosome. First mutation m
10
 is between 9 and 11 and is a true lethal 
mutation. The other mutation m
12
 located proximal to 11 and is actually a semi-lethal 
mutation because there were few escapers of male recombinants carrying this 
mutation. Since at this stage, the m
12 
mutation was isolated (Figure 27A). The 
germline clone analysis showed that m
12 
mutation didn‟t have maternal effect and 
could not generate the phenotype observed in original X161. Therefore, the m
10
 may 
be the mutation that caused the phenotype. 
Based on this assumption, another round of recombination was preformed to 
separate these two mutations and isolate the m
10
 mutation (Figure 27B). The y,pn, cv, v, 
x161
m10+m12
, f
-
, FRT
18E
 flies were crossed with the fly, w
118 
sn
3
 P{neoFRT}
19A
. The 
flies were treated with G418 to select the flies which contained P{neoFRT}
19A
 then 
progenies were crossed FM0 balancer and the recombinants with v
-
 and forked
+
 were 
picked up and setup stocks. Further SNP analysis with the SNP at 11 was preformed 
to select the stocks whose proximal mutations were removed.  
All the recombinants were tested by germline clones to check for the maternal 
effect. All the GLC embryos from the viable recombinants hatched, the GLC from all 
the recombinants containing m
10
 mutation did not hatched and showed premature 
cellularization phenotype similar to X161 (Table 2). This result indicated the 
phenotype was linked to the lethality. And the m
10
 mutation was indeed the mutation 
we were looking for. 
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Figure 27: The crossing-sheme of chromosome cleaning for X161. There two mutation, one 
at cyto 10 and one between 12 and 14 on the X chromosome of X161. The first chromosome 
cleaning (A) cleaned the X chromosome distal to v, and isolate the lines containing only m
12
 
mutation. The second chromosome cleaning (B) cleaned the proximal region and isolate the 
lines containing only m
10
, which is RPII215
X161
. 
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Table 5: the complement of the X161
m1
, FRT
9AE
 with duplication and deficiency lines.  
Duplication 
Stock Nr. Genotype Duplicated region FM0 WT 
929 Df(1)v-L15, y/C(1)DX, y w f; Dp(1;2)v[+]7 9A2;10C2 66 0 
5596 Dp(1;Y)BSC1, y[+]/w  10C1-2;11D3-8 177 30 
3560 Df(1)v-N48, f[*]/Dp(1;Y)y[+]v[+]#3/C(1)DX, y f 9F4;10E3-4 + 1A1;1B2  245 45 
29771 Dp(1;Y)BSC47 10B3;11A1 113 1 
29773 Dp(1;Y)BSC49 10B3;11A1 84 1 
29774 Dp(1;Y)BSC50  10B13-10C5;11A1 61 4 
29776 Dp(1;Y)BSC52 10C5-10C7;11A1 182 0 
29778 Dp(1;Y)BSC54 10C7-10D5;11A1 72 0 
29780 Dp(1;Y)BSC56 10D5-10E2;11A1 63 0 
30352 Dp(1;3)DC233  9F13;10A3;65B2 36 0 
30353 Dp(1;3)DC234 10A3;10A8;65B2 86 0 
30354 Dp(1;3)DC235 10A6;10B1;65B2 31 0 
30356 Dp(1;3)DC237 10B2;10B5;65B2 52 0 
30357 Dp(1;3)DC238 10B3;10B12;65B2 50 0 
30358 Dp(1;3)DC239 10B8;10B15;65B2 53 0 
30359 Dp(1;3)DC240 10B14;10C5;65B2 143 0 
30360 Dp(1;3)DC241 10C2;10D1;65B2 127 69 
30361 Dp(1;3)DC243  10D4;10E2;65B2 135 0 
30364 Dp(1;3)DC246  10F1;10F7;65B2 105 0 
Deficiency 
Stock Nr. Genotype Duplicated region Df/FM0 X161/Df 
23672 Df(1)BSC287 10A10;10B11 45 59 
23673 Df(1)BSC288 10B2;10B11 9 6 
25069 Df(1)BSC541 10E1;10F1 13 15 
25072 Df(1)BSC544 10E4;11B9 21 30 
26510 Df(1)BSC658 10B3;10C10 65 0 
26574 Df(1)BSC722 10B3;10E1 38 0 
1512 RPII215
1
 
 
193 0 
11547 RPII215
G0040
 
 
34 0 
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3.2.13. X161 is a novel allele of RNA polymerase II 215 subunit 
These new x161 recombinants are used for the complement test with duplication kit. 
Indeed, the chromosome-cleaned x161 could be complemented by two duplication 
lines 3560 and 5596, which narrowed the region of X161 as 9F to 10E. The further 
complement test with molecular-defined duplications and deficiencies was performed 
and narrowed to a 20KB region, from X: 11,446,970 to 11,466,244 (table 4, and 
figure 28A). There are 4 genes within this region, cg 1572, PGRP-SA, RNA 
polymerase II, and cg11699. The sequencing was performed for the genomic region of 
all four genes, which including the coding region, 5‟ UTR, 3‟UTR and the 1kb 
upstream. The sequencing revealed that there was a single nucleotide exchange from 
A to T at 40bp of the 3‟UTR of RNA polymerase II 215 subunit (Figure 28 C and D). 
To confirm that the X161 would be an allele of RNA polymerase II 215, the X161 
was crossed with two lethal alleles, RPII215
G0040
 and RPII215
1
 (GREENLEAF et al. 
1980). X161 failed to complement both (Table 4). Although the genomic rescue 
experiment is missing, combining the sequencing and complement test data still 
provids the convincing evidence that X161 is an allele of RPII215 (RPII215
X161
 
distinguishs from X161 in following section). 
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Figure 28: RPII215
X161
 is a novel allele of RNA polymerase II 215. The complement test with 
duplications and deficiencies narrowed down to four candidate genes (A &B). The enlarged 
illustration of the first 50bp region of 3‟UTR of RPII215 (C) The sequencing graph of the 
X161/FM7 show the double peak (T to A) at the point mutation of X161 (D), but  show only 
single peak of T in the control line X9/FM7 (E). The position of X161 mutation is indicated 
by the arrow.  
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Figure 29: Motif prediction of X161 mutation site. (A) The weight matrix of the predicted 
motif locates the X161 mutation site at 3‟UTR of RPII 215. (B) the sequence of this motif 
from 8 Drosophila species. (C) the location of this motif at 3‟UTR of the RPII in different 
species. (D) the sequence aligment of the first 50bp of 3‟UTR of RPII 215. The red box 
indicates the prediceted motif by MEME program. 
3.2.14. The prediction of X161 mutation site 
Next, I tried to use bioinformatic apporcah to predict the molecular nature of X161 
mutation. The sequence alignment show that the first 50bp of RPII 215 3‟UTR is 
conserved within 4 species in the melanogaster subgroup (Figuire 29 D, red box). The 
motif prediction by MEME program also predicted one 25bp motif located at X161 
mutation site (Figure 29A, B and C).  
Since the microRNAs paly an important role controlling the translation and RNA 
stability at early development (BUSHATI et al. 2008), we first checked whether there is 
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potential miRNA binding site at 3‟UTR of RPII 215 based on the data from 
miRNA-Target predictions for Drosophila miRNAs at EMBL (STARK et al. 2005; 
STARK et al. 2003). No miRNA binding site is reported at 3‟UTR of RPII 215. No 
piRNA binding site could be found at X161 mutation region with the blast of known 
piRNA database (SAI LAKSHMI and AGRAWAL 2008). We have not tested any the 
interaction of RNA-binding protein. However, Smaug, for example, may be a good 
candidate may bind to this position. 
3.2.15. Dynamics of RNA pol mRNA and protein 
Since RPII215
X161 
mutation occurred at 3‟UTR, it should not affect amino acid 
sequence. We hypothesized that the mutation may affect the translation rate or mRNA 
level. The western blotting against RNA polymerase II was performed. In wild type, 
there was low level of RNA pol II protein in 0 to 1 hr embryos (Figure 30A). Benoit 
and colleagues also obtained similar result (BENOIT et al. 2009). Both the active form 
and the total lever of Pol II protein gradually increase during the development. In 
RPII215
X161
 embryos, there is already high level of active Pol II protein at 0 to 1 hr 
embryos; however, the amount of Pol II remains constant. 
 
Figure 30: The dynamics of RPII215 protein and transcripts. (A) The western blot of RNA 
polymerase II 215 in early embryo. II0 is active form of Pol II IIa, inactive form. Pol II by 
ARNA3-a antibody, and II0 was by H5. The number above each lane indicates the collecting 
time (unit: hr) after egg deposition. II0 is the phosphorylated and active form of Pol II (B) the 
QPCR of RPII215 relative to actin. The overall level is significantly higher in X161 embryos. 
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Next, we investigated the dynamics of RNA polymerase II transcripts with 
quantitative PCR. The dynamic of Pol II mRNA show similar pattern as the protein. 
The level of transcripts is low for 0-2 hr, but the level rises from 2hr and boost during 
3 to 4 hr (Figure 30B). This result was contrary to the current genome-wide RNA 
sequencing result on flybase, that the level of RPII 215 transcripts was stable during 
whole life cycle (Figure 31) (DAINES et al. 2011). This may due to the different scale 
and experimental procedure. In X161 embryos, the initial level of Pol II mRNA is 
much higher than in wild type (Figure 30B). The high level of RNA polymerase II 
protein and transcripts is quite unexpected. It is unclear whether the rate of translation 
is higher in X161 at 0 to 2 hr. However, the high level of active form of pol II protein 
at the 0 to 1 hr may suggest that the accumulation of pol II protein and transcripts 
already start during oogenesis.  
 
Figure 31: the RNA-seq of RPII 215 in Drosophila (adapted from Daines 2011). The level of 
RPII 215 of 0-2 hr and 2-4 hr is similar, which is contrary to the QPCR result in Figure 29B. 
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4. Discussion 
4.1. Dissection of frs genomic regulatory module 
4.1.1. The genomic regulatory modules of frs expression 
In this study, we investigated the genomic regulatory elements of frs in order to 
provide the the link between the N/C ratio and the zygotic gene expression. Although 
we did not achieve this iniatial goal, our reporter assay narrowed the core genomic 
regulatory region of frs to the 260bp upstream region upstream of its transcription 
start site. The -260bp to -180bp region is required for the transcription of frs. The 
deletion of the region dramatically reduced the expreesion. We also identified two 
transcription silencers at the genomic regulatory region of frühstart. 
prom(-68--57)::GFPand prom(-174- -161)::GFP drives the leaky expression at cycle 
13, although the expression still delayed in haploid embryos (Figure 32). However, it 
supports the idea that there would be transcription represser to prevent the premature 
activation of frs. Since Frs is a cell cycle inhibitor which is sufficient to arrest the cell 
cycle, the expression of frs needs to be restrictively controlled at temporal aspect. The 
transcription repressor combined with activator can set a sharp expression broader 
than the activator alone (DAVIDSON 2001).  
 
Figure 31: the genomic regulatory region of frs. The putative enhancer and the 
protein-bindong region is in blue. Two putative silencers (in orange) prevent the premature 
expression at cycle 13. The TAGteam motic is in pink, TATA box in green. The number below 
indicate the distance (bp) from the transcription start site. 
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In our EMSA assay, we identified one protein-binding motif at -260bp to -211bp at 
the region is required for the strong expression of frs (Figure 32). This motif may be 
an enhancer for the transcription activation. This region is conserved within D. 
melanogaster, D. simulans, and D. yakuba (all in melanogaster subgroup), but quite 
variable in other species. This may be the reason why this motif is not over-presented 
in MEME predication. We did not attempt to purify the protein binding to this motif. 
But it is worth to investigate it with DNA affinity chromatography or yeast-one hybrid 
screen. 
We could not detect any DNA-protein interaction at the region of prom(-68--57) 
and prom(-174- -161) in our EMSA assay using nuclear extract from the early embryo. 
EMSA is proofed to be a very powerful tool for investivgating the interaction between 
nuclear acid and proteins and is widely used in DNA and RNA researches. However, 
the binding interaction of EMSA is performed in vitro at reaction tube suppilied by the 
artificial buffer. The DNA probe using in EMSA are usually short (less than 500bp) 
and is without histone or DNA modification. Therefore, the EMSA could not fully 
provide the microenviroment identifical to the transcrion factors encounter in nuclei, 
especially the weak DNA-protein binding or the binding requied other factors. 
Another reason is the abundence of transcription factors. The amount of transcription 
factor is relative low compared to other nuclear protein. In early cleavage stage, the 
number of nuclei is fewer than in syncytial blastoderm or later stage. Therefore, the 
nuclear extract we used in this study may not contain sufficient transcription factor to 
mediated the shift in EMSA. The third possibily is that this motif may not be directly 
involved in protein binding. Although this two motifs are required for the repession at 
cycle 13, it may mediate the repression by change the local DNA topology, for 
example, the motif makes it more difficult to bend DNA and form the loop which is 
__________________________________________________________________________Discussion 
92 
 
required for the interaction between transcription acvitator and RNA polymerase II 
complex (TADROS et al. 2007a).  
 
4.1.2. The TAGteam motif is not required for frs expression 
The transcription of frs is largely decreased in the microarray analysis of zelda 
mutant, and about 5 to 10% of zelda mutant embryos undergo extra mitosis as in frs 
mutant (LIANG et al. 2008). These two results suggest that the expression of frs 
requires the transcription factor Zelda. The Zelda binds specificly to the TAGteam 
DNA motif (CAGGTAG). There is one CAGGTA motif located at 127 to 121 bp 
upstream of the frs transcription start site. However, in our study, substitution of this 
motif did not alter the expression of the reporter. It suggests that TAGteam motif is 
not required for the expression of frs. It is possible that there is alternative Zelda 
binding site which is not a typical cAGGTA motif or that Zelda indirectly affect frs 
expression by controlling other transcription factor. 
4.1.3. In situ hybridization as a tool studying temparol expression 
In our study, we use in situ hybridization as read out of reporter constructs for 
several reasons: first, the early cell cyles in drosophila are short. the interphase 13 
takes about 20min. The normal translation and activation of GFP takes at least 30min, 
as other reporter protein, like luciferase. Second, the RNA level is what we were 
really interested in, although the preotin level correlate with mRNA level, but it is still 
indirect. Second, we use the nuclear density as an indicator which cycles the embryo 
is. Therefore, the embryo needs to be fixed and stained by DAPI. The in situ 
hybridization is very powerful for investigation of spatial expression, since it provides 
more expression. However, it could only provide qualitive data but not quantitative 
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data. This caused some problem in this study. The staining was sometimes faint and 
difficult to decide whether it is expressed.  
Lu has showed that it is possible to hand-select the staged embyos for each cycle 
with the histone-RFP labeling the nuclei under fluorescence stereo microscope (LU et 
al. 2009). It would be a better detection method for our study to use QPCR for 
hand-select staged embyos. 
4.1.4. The N/C ratio and number of cleavage cycles 
The relation between N/C ratio and number of cleavage cycles is known for almost 
one hundred years (KORZH 2009). However, the molecular link between N/C ratio and 
cell cycle mechanism remain unclear. Lu and Wieschaus has identified 88 zygotic 
genes whose expression delay in haploid embryos (LU et al. 2009). Based on this 
finding and the previous work about frs in our lab, we hypothesized that the frs can 
provide the missing link between N/C ratio and cell cycle control. Because the 
expression of frs is respond to N/C ratio and Frs is a cell cycle inhibitor. Although we 
identified two cis-motifs which prevent premature expression at cycle 13, we could 
not identify the element responsive to the N/C ratio. One possibility is that this 
element may be an activatior which is required for frs expression, therefore, we could 
not identify it via deletion or substitution constructs. To test this, we would need to 
add the minimal frs regulatory module to the promoter of the zygotic gene which is 
not regulated by N/C ratio and see whether the fusion promoter can response to the 
N/C ratio. 
4.1.5. Outlook for the imvestigation of frs genomic regulatory elements 
So far we could not identify the elements responsive to the N/C ratio. We would 
like to improve this study by following: first, using quantitative method to measure 
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the level of trancripts. Second, use yeast-one hybrid screen to indetify candidate 
DNA-protein interaction (SIEWEKE 2000). The advantage of yeast-one hybrid system 
is the interaction is in vivo, and it can identify the candidate proteins which bind to the 
DNA. We hope that we could eventually identify the cis and trasn factors which 
respond to N/C ratio and provide the missing link between N/C ratio and cell cyele 
stop.  
4.2. The Role of RPII215 in controlling the onset of MBT 
4.2.1. RPII 215
X161
 is a novel allele of RNA polymerase 215 subunit 
In this study, we reported a special allele of RNA polymerase II 215, RPII 215
X161
, 
which contains one single T to A mutation at 40bp downstream of the stop codon. 
Several lines of evidences supported this conclusion. First, the sequencing result 
showed there was only one point mutation within the genomic region of four 
candidate genes. Second, two RPII215 allele, RPII215
G0040
 and RPII215
1
 can not 
complement the lethality. Third, the duplication line Dp(1;3)DC241 resuced both the 
lethality and maternal effect. RPII 215
X161
 caused the premature onset of MBT, which 
includs the cell cycle pause, maternal-zygotic transition and cellularization. Since the 
mutation occurs at 3‟UTR, we assume it may affect the translation efficieny and RNA 
level as it changes the level of both transcripts and protein.  
We could not find putative factor binding to X161 mutation site, therefore could not 
provide the molecular evidence how the X161 point mutation caused the phenotype. 
But the data of western and QPCR show that even the initial amount of Pol II protein 
and transcripts is high in 0 to 1hr embryos. It suggests the accumulation of Pol II may 
already start during oogenesis. This raises another question: whether the level of other 
maternal transcripts also increase in the egg. The genome-wide analysis of 
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unfertilized eggs would help to clarify it.  
 
Figure 33: The models for phenotype of X161 mutant. In wild type (A), the active Pol II 
protein gradually increases and enables the zygotic gene expression with the help of 
transcription factor. In direct model (B), the higher amount of Pol II pol II protein in 
preblastoderm is the main force driving the  
4.2.2. Two models for RPII 215
X161
 phenotype 
Based on the western blot and QPCR, we proposed two models to explain how 
RPII 215
X161
 causes the premature onset of MBT. In wild type, the level of RNA 
polymerase II protein is low after egg deposition, but is gradually increased by 
translation. When the amount of Pol II protein reachs a threshold, it starts the 
transcription of zygotic genes with the help of transcription factors (Figure 33A). 
Zygotic-expressed factors inhibit the cell cycle progression and promote 
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cellularization.  
In our first model, the direct model (figure 33B), RPII 215
X161
 affect the translation 
of Pol II protein, and generat high amount of active Pol II protein in preblastoderm. 
Pol II protein therefore forces the premature zygotic gene activation and eventually 
initiates mid-blastula transition. 
The indirect model (Figure 33C) emphasizes the change during oogenesis. The 
amount of Pol II protein is already higher in oogenesis. This may affect the 
transcription of many maternal genes. The amount of many maternal transcripts are 
higher in the egg as RPII215, probably the protein as well. These premature translated 
maternal proteins, like Zelda and Smaug, together with Pol II protein promote the 
premature expression of zygotic genes, and lead to premature MBT. 
No matter how RPII 215
X161
 promotes the premature zygotic gene expression. The 
expression of zygotic genes is required for the premature onset of MBT, as the 
α-amanitin injection showed. 
4.2.3. The Regulation of onset of Zygotic Gene Activation 
Even that the amount of active Pol II protein was much higher in preblastoderm of 
RPII 215
X16
; zygotic genes we tested were expressed only one cycle earlier than in 
wild type. This suggests that other factors are also required for zygotic gene 
expression (Figure 34). During the early nuclear divisions there are only S phase and 
M phase, which the DNA is either during DNA synthesis or packed into compact 
chromosome structure. This inhibits transcription. This may explain why there is no or 
very less transcription until cycle 10 when the interphase is prolonged. However, the 
length of interphase 12 did not prolonged in X161 embryos, but is able to transcript 
the sufficint amount of zygotic genes required for MBT. It suggested that prolonged 
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gap phase may be required passively, but it is not the switch for onset of zygotic gene 
activation. Another possible negative factor for transcription in early divisions is the 
epigenetic modification on DNA or histones. The DNAs are highly methylated and 
the transcription of zygotic genome is repressed in vertebrates (FENG et al. 2010). 
There would be also transcription repressors contributed to the inhibition of 
transcription in early embryo and defince a sharp cut of expression as our frs project 
showed. Romoval of these repressors is also required for the zygotic gene expression. 
This may mediate partily by the RNA degradation of the repressor transcripts by 
RNA-binding protein Smaug (BENOIT et al. 2009; TADROS and LIPSHITZ 2009). 
Another requirement is the availability of transcription activator. The main 
transcription activator for zygotic genes is Zelda. Zelda protein can be detected only 
after cycle 10 (LIANG et al. 2011; NIEN et al. 2011). Zygotic gene activation is 
regulated by multiple factors to setup at proper timing. In this study, we found out that 
the accumulation of RNA polymerase II is not only required but also sufficient to 
promote zygotic gene activation and MBT. 
 
Figure 34: Summary of the known and predicted factors controlling the onset of ZGA. Blue 
box lists the known factors may promote ZGA, including the prolonged interphase, the 
accummlation of active Pol II, translation of transcription factor Zelda, and translation of 
RNA binding protein Smaug. The red box lists the negative factors for ZGA, including the 
rapid cell cycle, maternal transcription represser, compact chromosome structure, and 
epigenetic repression, like DNA methylation 
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4.2.4. The Coupling of Cell Cycle Pause and Cellularization 
McCleland and O‟Farrell have performed the experiment with RNAi against 
mitotic cyclin in early embryos (MCCLELAND and O'FARRELL 2008). The embryo 
with RNAi against Cyclin A and Cyckin B would stop cell cycle prematurely, and the 
cellularization still began at the absolute time of the development. It leads to the 
conclusion that the uncoupling of the cell cycle and cellularization, and suggests cell 
cycle and cellularization are controlled by different mechanism (MCCLELAND and 
O'FARRELL 2008). However, in X161 germline clone, the cellularization do occurred 
immediately after the last mitosis. We propose that the result causes the different 
outcome is the premature expression of cellularization-related zygotic genes, such as 
nullo and slam. We hypothesis that as long as these proteins required for 
cellularization are presented in embryo, the furrow channel invegination would start 
during interphase.  
4.2.5. Role of zygotic transcription in timing and coordination of MBT 
MBT describes the assembling of changes occur at roughly the same time. However, 
these events may not be controlled by the same mechanism (YASUDA and SCHUBIGER 
1992). However, our data put the zygotic activation at the center of MBT, and 
therefore coordinate all the other events (Figure 35). The cell cycle control at MBT 
required the zygotic cell cycle inhibitor, like Frs, and also the zygotic mediated 
removal of stg and twn transcripts. The degradation of maternal transcripts may 
contribute to the zygotic gene expression, but the majority of maternal transcripts is 
depredated by zygotic-expressed miRNAs. Finally the cellularization also required the 
zygotic genes, like slam and nullo.  
The regulation of zygotic genes is not homogenous. There are two categories, N/C 
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dependent and N/C independent. These two different regulations can sense the 
internal cue (via the N/C ratio) to generate sufficient number of reasonable-size cells, 
but also can sense the environment cue (probably by N/C independent mechanism) to 
ensure the smooth and successful development at different conditions. Therefore, the 
coordination of two distinct regulatory pathways for zygotic gene activation makes 
the development more flexible and robust.  
 
 
Figure 35: The role of zygotic gene activation during mid-blastula transition. The 
zygoic genes are required and sufficient to trigger the other events on MBT 
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